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Extensive research indicates that false-positive mammograms (FPM) have been 
associated with negative psychosocial and cancer-related beliefs, but only a handful of 
studies examine Black women’s reactions to this experience. Additionally, these studies 
do not investigate how organizational and provider-level factors in concert with 
individual patient characteristics shape Black women’s experiences and reactions to FPM 
results. The purpose of this study was to determine the impact of organizational, provider, 
and individual-level factors on the processes and outcomes associated with FPM results 
in Black women. This study had two specific aims: 
1) To describe, using a mixed methods approach, the organizational and provider-
level characteristics of mammography facilities and their impact on Black women’s FPM 
experiences and outcomes. 
2) To determine, through quantitative methods, the relationship between receiving 
a FPM result and future mammography intention among Black women. 
Two phases of data collection were conducted as part of this study. Phase I began 
in March 2016 and concluded October 2016. Observations, key informant interviews, 
provider surveys, and analyses of screening and diagnostic data were used to describe the 
facility and provider-level characteristics of five mammography screening centers in the 
Columbia, South Carolina Metropolitan Statistical Area (MSA). Organizational and 
provider data collected during Phase I were linked to patient survey data collected during 
Phase II. The patient survey tool contained items that assessed demographic 
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characteristics, breast cancer (BrCa) screening history, emotional states, coping 
behaviors, cancer-related beliefs and attitudes in Black women with FPM and normal 
results. Black women aged 40+, breast cancer free, who completed screening 
mammograms from January to August 2016 at one of the previously mentioned screening 
centers were eligible to participate. Women who received a FPM result were selected as 
cases, matched controls were selected from women screened on the same day and site but 
had normal mammograms. Patient surveys were administered from July 2016 to January 
2017. Of the 132 patient surveys returned, 117 met the criteria for study inclusion.  
No facility, provider, or patient factors were associated with two types of 
satisfaction: general and provider interpersonal style. FPM status was one of several 
patient characteristics associated with lower levels of satisfaction with convenience and 
provider information communication. Facility and provider-level factors had negative and 
positive effects on satisfaction with provider competence. Satisfaction with the clinical 
environment was also influenced by facility characteristics. FPM status was only 
associated with a higher perception of barriers to mammography, and perceived barriers 
were associated with a lower intention to complete mammography. Afrocentric coping 
behaviors moderated the perception of mammography barriers for women with FPM 
results, weakening this relationship.  
A variety of organizational, provider, and individual-level patient factors were 
found to influence the processes and outcomes associated with FPM among Black 
women. Receipt of FPM results appear to have a detrimental effect on mammography 
satisfaction and intention in in Black women, but culturally-relevant behaviors such as 
collective coping strategies may reduce the negative effects of FPM status. Study results 
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reinforce the need for incorporating culturally-appropriate theoretical influences and the 
operationalization of those influences to understand the contributions to racial inequities 
in BrCa burden. 
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1.1. Breast Cancer Burden 
Despite steady declines in overall cancer mortality during the past three decades, 
cancer remains the second leading cause of death in the United States.1 The burden of 
cancer varies by gender as a result of sex-specific cancers such as BrCa. BrCa is the most 
commonly diagnosed cancer in American women and the second leading cause of cancer 
deaths in this population.1 In 2015, it is estimated that 40,290 American women died of 
BrCa.2 BrCa mortality rates have increased by 0.4% per year in the United States until 
1989, when BrCa mortality began a steady decline which continues to this day.2 
Advances in the science and adoption of breast conservation surgery, adjuvant 
chemotherapy, and tumor detection resulted in a 36% decrease in overall BrCa death 
rates between 1989 and 2012.2,3 Due to the enduring presence of racial disparities through 
the breast cancer continuum, BrCa mortality has decreased at a much slower rate among 
Black women.  
1.2 Racial Disparities in Breast Cancer Burden 
 Current BrCa mortality rates are 30.0 and 21.2 per 100,000, among Black and 
White women, respectively.1 This disparity represents a 42% higher BrCa death rate in 
Black women and is due to slower declines in BrCa mortality (-1.8% in Whites vs. -1.4% 
in Blacks).1 Black-White inequities in BrCa death rates are driven by a plethora 
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of interconnected biological, economic, social, cultural, and health system factors.2,4–7  
Racial differences in BrCa incidence trends, disease progression, and treatment 
are the primary drivers of Black women’s increased BrCa mortality.8–10 Between 1992 
and 2012, BrCa incidence rose by 0.4% annually for Black women while remaining 
constant in White women.2 In contrast to the historically higher BrCa incidence rates for 
White women 50 years of age or older, Black and White women in this age group now 
have similar rates (125.1 and 128.3 per 100,000 women, respectively).1 These trends in 
combination with the fact that Black women are more likely to be diagnosed with larger 
and advanced staged tumors have negative implications for treatment success and 
subsequent mortality in this population.11–13 
BrCa treatment-related disparities encompass issues related to Black women’s 
access to appropriate therapies and treatment delays.8,14–16 Treatment delay consists of 
two components: delays in initiating treatment post receiving a diagnosis of BrCa and 
delays in completing diagnostic testing after symptom detection or notification of an 
abnormal screening test (diagnostic delays).17,18 Diagnostic delay has emerged as a 
significant behavioral factor explaining poor BrCa prognosis in Black women through its 
contribution to advanced tumor stage at diagnosis and the influence on the timeliness of 
the start of treatment.15,16,19–21 Black women are less likely to complete diagnostic testing 
within the desired 60-day window than their White counterparts.16–18,20,22,23 Much 
research has been devoted to understanding the causes and mechanisms responsible for 
this behavioral trend, but no one factor explains this phenomenon.  
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1.3 Contributions to BrCa Diagnostic Delay in Black Women 
 Of the many determinants of diagnostic delay among Black women, individual-
level factors have received the most attention.24,25 Sociodemographic characteristics that 
impact healthcare access including:  income, health insurance, and employment status, 
have been most frequently cited as leading to diagnostic delay.16,20,24,25 Lack of 
knowledge regarding BrCa screening, attitudes such as fear, and cancer-related beliefs 
like cancer fatalism, have also been thought to affect Black women’s motivation to 
complete follow-up testing.20,24,25 Clinical aspects of the BrCa screening population 
include: non-adherence to mammography screening guidelines and self-detection of 
tumors as opposed to mammography are also associated with diagnostic delays.16,19,26–28  
1.4 Previous Mammography Screening Experiences and Diagnostic Delay 
Prior research on the characteristics associated with follow-up delay in Black 
women has paid little attention to Black women’s previous screening experiences and 
their potential to influence the completion of diagnostic testing. Outside of studies of 
racial discrimination and mistrust in the clinical encounter, virtually no efforts have 
quantitatively linked past mammography experiences to Black women’s attitudes towards 
diagnostic testing.29–33 Black women’s history of FPM results may be an importan,t but 
understudied aspect of their screening experience.  
One qualitative study of Black BrCa survivors presented accounts of women who 
delayed seeking care for lumps due to past FPM results.34 Another study by Kerner et al. 
examined multilevel influences on follow-up delays among Black women. Kerner et al. 
found that Black women with previous FPMs were 60% more likely to have diagnostic 
delays than Black women without a history of FPMs.35 Additionally, study participants 
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with higher levels of cancer anxiety were less likely to complete their diagnostic follow-
up within the recommended 90-day window.35 Both studies indicate a possible 
connection between prior FPM results and mammography delay in Black women. 
1.5 False-Positive Mammography Results  
A FPM result is defined in health research literature as a screening mammogram 
that requires additional follow-up testing, but does not lead to a cancer diagnosis.36–38 
Clinically, FPMs correspond to a Breast Imaging-Reporting and Data System (BI-RADS) 
classification of 0 (i.e., additional imaging evaluation and/or comparison to prior 
mammograms in needed), 3 (i.e., probably benign finding), 4 (i.e., suspicious 
abnormality) or 5 (i.e., highly suggestive of malignancy) that is confirmed as non-
malignant through one or more of the following procedures: diagnostic mammogram, 
ultrasound, breast MRI, or biopsy.39 Normal mammograms are classified as BI-RADS 1 
or 2.40  
Anywhere from 5-10% of mammograms each year result in a FPM, but 
cumulatively a woman has a 20-65% chance of receiving a FPM result depending on the 
age at which she initiates screening (40 or 50 years old), her screening schedule (annual 
vs. biennial), and her risk for FPM.41–44 Younger women (age 40-49), women with 
heterogeneously dense breasts, those with a family history of BrCa, and previous FPM 
results are at increased risk of receiving a FPM result.45 FPM rates are generally the same 
for Black and White women, but facility and provider characteristics have been 
documented to affect the prevalence of FPM in various racial groups.45–48 National data 
indicate the that rates of abnormal mammography results have risen in recent decades.49 
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Recommended mammography screening intervals have been lengthened in part due to 
potential harms to women as a result of FPM.50–52 
1.6 Impact of FPM Among Black Women 
FPM results may lead to potentially negative patient-level outcomes, such as 
additional financial costs due to follow-up testing, impaired daily function, negative 
emotional states, and reduced levels of future BrCa screening intention and behavior.37,38 
What, if any, effects FPM results may have on Black women’s satisfaction with their 
mammography experiences, BrCa related beliefs and attitudes, and/or future screening 
and follow-up behaviors is largely unknown due to the lack of research on FPM in this 
population.  
Black women in the United States inhabit different social, environmental, 
economic, and cultural contexts than White women. As such these contexts impact Black 
women’s BrCa risk and knowledge.53–56 Black women’s access to cancer screening 
services is impacted by the quality of facilities and providers through residential 
segregation.48,57,58 Extensive literature exists to describe the communication challenges 
Black women face while navigating the healthcare system.59–62 The actions Black women 
employ in the face of these challenges are shaped by cultural and social norms for 
behavior within and outside the Black community. Thus, their experiences and outcomes 
cannot be fully represented by research consisting of predominately White participants.63 
Being that “Black women are not White women plus color, or Black men, plus gender”64, 
research studies centered on Black women’s experiences and grounded in relevant 




1.7 Specific Aims 
The purpose of this study was to determine the impact of organizational, provider, 
and individual-level factors on the processes and outcomes associated with FPM results 
in Black women. The study was conducted in two phases and had two specific aims: 
Specific Aim 1: To describe, using a mixed methods approach, the organizational 
and provider-level characteristics of mammography facilities and their impact on Black 
women’s FPM experiences and outcomes. 
Research Question 1.1. What organizational, provider, and patient-level 
characteristics predict high levels of satisfaction with their clinical encounter among 
Black women experiencing a FPM result? 
Specific Aim 2: To determine, through quantitative methods, the relationship 
between receiving a FPM result and future mammography intention among Black 
women. 
Research Question 2.1. What is the relationship between receiving a FPM result 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) among Black women? 
Research Question 2.1.a. Do Black women’s emotional states explain the 
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of 
mammography, perceived BrCa susceptibility, and perceived barriers to mammography 
screening)? 
Research Question 2.1.b. Does the relationship between receipt of FPM results 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
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susceptibility, and perceived barriers to mammography screening) vary by the coping 
strategy employed? 
Research Question 2.2. What is the relationship between BrCa behavioral beliefs 
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived 
barriers to mammography screening) and the intention to complete future mammography 
screening? 
The next chapter will provide background information on the burden of BrCa 
among Black women and the role of mammography and follow-up testing in South 
Carolina. A review of the research to date on the prevalence, influences, and outcomes 





BACKGROUND AND SIGNIFICANCE 
 This chapter provides background on recent epidemiological and behavioral 
trends as they relate to BrCa burden among Black women and potential influences on 
these trends. 
2.1 Cancer in Black Women 
Cancer is the second leading cause of death among American women.66 It is 
estimated that BrCa was responsible for 19% of cancer deaths in 2016, making it the 
second leading cause of cancer deaths among Black women in that year.67 BrCa is also 
the most prevalent cancer among Black women as it represents an estimated 32% of 
cancer incidence for this group in 2016.67  
2.2 Epidemiology of Breast Cancer in Black Women 
2.2.1 Racial trends in breast cancer burden in the United States 
In the United States, Black women have disproportionately higher BrCa mortality 
rates than any other racial and ethnic group.2 This trend began in the late 1990’s due to a 
slower decline in Black women’s BrCa mortality relative to White women (-1.4% and -
1.8% percent annual change, respectively).67 Between 2010 and 2014, BrCa mortality 
rates were 30.0 per 100,000 in Black women and 21.1 per 100,000 among White women 
which represents a 42% higher death rate for Black women.1  
In contrast, BrCa incidence has increased by 0.4% annually among Black women 
between 2008 to 2012, while remaining stable for White women.2,68 Historically, 
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BrCa incidence rates were highest in Black women under the age of 40, but higher among 
White women over the age of 50.69,70 Recently, BrCa incidence in Black and White 
women over the age of 50 has converged.2,7,71 Current five-year incidence rates (2009-
2013) are essentially the same for Black and White women (125.1 and 128.3 per 100,000, 
respectively). Higher BrCa incidence among Black women over 50 has the potential to 
increase BrCa mortality, thus widening the current racial disparity in BrCa burden. This 
trend is especially notable in the Southern US, with South Carolina serving as a typical 
example.7 
2.2.2 Racial Trends in Breast Cancer Burden in South Carolina 
South Carolina contains 46 counties which are organized into four regions by the 
South Carolina Department of Health and Environmental Control (See Figure 2.1). The 
Columbia, SC MSA includes Richland, Lexington, Saluda, Fairfield, Kershaw, and 
Calhoun counties and is largely located within South Carolina Department of Health and 
Environmental Control’s Midlands region (See Figure 2.2). The most recent five-year 
average (2009-2013) of BrCa incidence in the Columbia SC MSA was 132.0 per 100,000 
which is above the Midlands region average of 127.8 per 100,000 or the state average of 
127.2 per 100,000.72 BrCa mortality in the Columbia, SC MSA (23.7 per 100,000) was 
similar to the regional and statewide mortality rates (22.8 and 22.4 per 100,000) during 
that time period.72 
In addition to increased BrCa burden, the Columbia, SC MSA displays significant 
racial inequities in BrCa burden. This disparity has increased since the racial convergence 









Figure 2.2 Map of Columbia, SC Metropolitan Statistical Area 
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geographic location for 2012 and 2013 are presented in Table. 2.1. Black women in the 
Columbia, SC MSA had higher rates of BrCa incidence (139.5 and 130.0 per 100,000) 
and mortality (31.8 and 20.3 per 100,000) compared to White women.72 The Columbia, 
SC MSA will require special attention to ensure that BrCa inequities do not widen.  
Table 2.1 2012-2013 Breast Cancer Incidence and Mortality by Race and 
Location72–74 
Location Incidence (Per 100,000) Mortality (Per 100,000) 
 White Black White Black 
Columbia MSA 130.0 139.5 20.3 31.8 
DHEC Midlands 125.2 134.6 20.3 29.4 
South Carolina 128.2 127.9 19.3 28.5 
United States 124.3 122.1 20.5 28.8 
 
2.3 Contributions to Increased Breast Cancer Burden Among Black Women 
Differences in BrCa risk factors; comorbid conditions, and tumor characteristics 
at/prior to diagnosis; as well as the quality, effectiveness, and adoption of treatment 
modalities are responsible for the elevated BrCa death rates among Black women.6,67 Pre-
diagnostic differences in BrCa burden among Black women may lead to future increases 
in BrCa mortality in this group. Mixed evidence suggests that reproductive factors such 
as age at menarche and age at first pregnancy may increase the risk of different BrCa 
subtypes in Black women based on age and/or menopausal status.75–77 Obesity and 
diabetes also increase BrCa risk and are suspected to be driving forces responsible for 
increasing BrCa incidence among Black women.2,68  
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Upon diagnosis, differences in disease severity also drive increased BrCa 
mortality experienced by Black women.9,15,19,78–81 Black women are more likely to be 
diagnosed with stage II, III and IV tumors compared to White women.15,19,78,82 After 
controlling for socioeconomic and biological factors, delays in breast cancer diagnosis 
and treatment have been documented as significant contributors to advanced staged 
breast cancer in Black women.10,15,16,27,80,83–85  
2.4 Racial Inequities in Breast Cancer Screening 
Recent data from the 2015 National Health Interview Survey indicated that Black 
women complete screening mammograms at somewhat higher rates than White women 
(69.7% and 65.8%, respectively).66 Behavioral Risk Factors Surveillance System data 
from 2014 reports similar screening trends in South Carolina with 81.4% of Black 
women reporting use of screening mammography compared to 74.4% of White women.86 
Despite higher initial screening rates, Black women are less likely to complete follow-up 
screening tests if their initial mammogram reveals an abnormality.15,16,27,83,85 
2.5 Addressing Mammography Follow-Up Among Black Women 
Delayed mammography follow-up in Black women has been attributed to lower 
levels of BrCa knowledge, BrCa related attitudes and beliefs, socioeconomic factors, and 
issues related to healthcare access.24,87,88 Recommended client-oriented approaches for 
increasing BrCa screening include: small media, group and one-on-one education 
programs, such as Black Corals and the Witness Project, which address racial differences 
in BrCa knowledge and beliefs, and system level interventions like the National Breast 
and Cervical Cancer Early Detection Program, and patient navigation focus on removing 
structural barriers.89–94 All of the previously mentioned programs and strategies have 
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been implemented in South Carolina and have had positive impacts on BrCa screening 
among Black women in the state. 
2.5.1 Evidence-based Strategies to Improve Mammography Follow-Up Among 
Black Women 
The Black Corals program was developed by the St. James-Santee Family Health 
Center in collaboration with the South Carolina Department of Health and Environmental 
Control in 2008.95,96 Community-based group education sessions provided education 
about BrCa risk factors, symptoms, detection and screening resources.95,96 Together with 
a media campaign, client and provider reminders, the program lead to increased screening 
rates and a reduction in the rates of missed appointments.95,96 
Around the same time, a statewide lay education program was developed by the 
National Cancer Institute-funded Community Network Program Center in South 
Carolina, the South Carolina Cancer Disparities Community Network-II (SCCDCN-
II).97–99 The SCCDCN-II was a partnership between academic researchers and members 
of a statewide Black faith organization.100 Together, members of the SCCDCN-II 
implemented the South Carolina Witness Project, an evidenced-based group education 
program that is culturally tailored to provide BrCa education to Black women.101,102 
Women in the program demonstrated increased BrCa knowledge, decreased cancer 
fatalism, and increased screening intentions after participating in the community 
education sessions.103 
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) 
is one of the largest programs focused on addressing known barriers to mammography 
follow-up with special attention to racial and ethnic minorities such Black women.91,104 
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The NBCCEDP consists of several activities such as the building of an infrastructure to 
support the delivery of and reimbursement for BrCa screening and diagnostic services, 
the provision of education and outreach services to support the recruitment of eligible 
women, and the delivery of case management services and patient navigation to support 
women as if they receive abnormal results.91,104 In South Carolina, the NBCCEDP funds 
the Best Chance Network (BCN) which is administered by DHEC’s Division of Cancer 
Prevention and Control.91,105 Since 1991, BCN has provided BrCa and cervical cancer 
screening services to South Carolina residents aged 40-64 with incomes at or below 
200% of the federal poverty level.91,105  
The NBCCEDP has made significant progress in providing BrCa screening and 
diagnostic procedures to low income women and women of color, but the program’s 
efforts alone are not enough to reduce the BrCa burden in Black women. A comparison 
of BrCa burden among NBCCEDP and non-NBCCEDP participants indicate that Black 
participants were more likely to have late staged disease compared to Black women who 
did not participate in the program.106 Across all groups of program participants, Black 
women and women residing in the South were also more likely to present with late staged 
disease.106 While the NBCCEDP has reduced participants’ time from initial screening to 
diagnosis (diagnostic interval) between 1996 to 2005, Black women and other women of 
color continue to have longer diagnostic intervals than White women.92 
Patient navigation is another strategy that has been used address disparities in 
BrCa screening and diagnostic follow up.93,94 As described by Dr. Harold Freeman, who 
developed this model to address cancer disparities in Harlem in the 1980s, patient 
navigators are lay persons from the same cultural and/or local communities as the patient 
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population they serve.93,107 These lay persons are trained to assist patients in “navigating” 
the healthcare system and overcoming the various cultural, social, systemic, and logistical 
barriers that prevent patients from getting the recommended cancer care.93,107  
The NBCCEDP is one of many programs which incorporates the use of patient 
navigation to improve cancer care among Black women.104,108 While patient navigation 
has been effective in reducing delays in the resolution of abnormal screening results; 
Black participants continue to display longer diagnostic follow-up intervals compared to 
their White counterparts even after controlling for factors such as the number of barriers 
to diagnostic resolution or health insurance type.17,109–111  
2.6 Influence of Screening History on Black Women’s Screening Behaviors 
Despite these programs, racial inequities in the time between BrCa detection and 
diagnosis persist.15,16,79,83,85,92,109 The enduring nature of BrCa screening inequities points 
to gaps in understanding how various factors influence BrCa screening behaviors in 
Black women. Much of the research on this phenomenon examines BrCa screening 
knowledge, cultural beliefs, structural/logistical barriers to screening, but few studies 
have examined the role of past screening history.24,87,88,112 One screening outcome that 
has received little attention, but may hold the key to explaining delayed follow-up among 
Black women, is receiving a FPM.  
Black women’s history of abnormal mammography results may be an important, 
but understudied aspect of their screening experience. One qualitative study of Black 
BrCa survivors presented accounts of women who delayed seeking care for lumps due to 
past abnormal screening mammograms that were found to be non-cancerous.34 Another 
study by Kerner et al. examined correlates of delayed follow-up in a sample of Black 
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women with abnormal screening mammograms.35 Women who completed 
mammography follow-up after the 90-day window were more likely to have had an 
abnormal mammogram in the past, displayed higher levels of anxiety compared to those 
completed follow-up within the window, or had a screening mammogram designated as 
incomplete or inconclusive compared to those designated as highly suspicious or 
potentially malignant (BI-RADS 0 vs 4/5).35 Both studies indicate a possible connection 
between prior abnormal mammograms and mammography delay in Black women. 
2.7 Definition and Epidemiology of False Positive Mammograms 
FPM is the term used in public health research to describe a screening 
mammogram with an abnormal result that is confirmed as non-malignant through one or 
more of the following procedures: diagnostic mammogram, ultrasound, breast MRI, or 
biopsy.37,113,114 Clinically, FPM results correspond to a BI-RADS classification of 0 
(Incomplete - additional imaging evaluation and/or comparison to prior mammograms in 
needed), 3 (Probably benign finding), 4 (Suspicious abnormality) or 5 (Highly suggestive 
of malignancy).39 Normal mammograms are classified as BI-RADS 1 or 2.39  
Anywhere from 5-10% of mammograms each year result in a FPM, but 
cumulatively a woman has a 20-65% chance of receiving a FPM result depending on the 
age at which she initiates screening (anytime between 40 and 50 years of age) and her 
screening schedule (annual vs. biennial).37,41–43,114,115 FPM may lead to potentially 
negative outcomes, such as additional financial costs due to follow-up testing, impaired 
daily function, negative emotional states, and potentially reduced BrCa screening 




2.7.1 Influences on False Positive Mammography Rates 
Biological patient characteristics, such as older age, breast density (as measured 
by BI-RADS density classification), being premenopausal, having a family history of 
BrCa, and for women in the 40-59 age range a low BMI, have been associated with 
increased likelihood of receiving FPM results.45,114,118 Several aspects of a patient’s 
previous screening history also lead to future FPM results: having a FPM result in the 
past, if this the patient’s first or subsequent screening mammogram of her BrCa screening 
life, the availability of previous mammography images, and shorter screening 
intervals.45,114,118,119 
Provider and facility characteristics also drive FPM rates, but is not entirely clear 
how these factors influence FPM rates at the mammography facilities Black women 
use.46,120–125 Radiologists who were older, male, with more clinical experience, or read 
less than 1,500 scans annually had lower FPM rates.47,122,123,125 Additionally, completing 
a breast imaging fellowship and reporting concerns about malpractice was associated 
with higher FPM rates among radiologists.47,122 One study documented radiologists 
recalling Black women for additional testing at higher rates than White women, but it not 
entirely clear if this is related to variations in screening history between Black and White 
women.124 Facility-level characteristics, such as providing radiologists with audit data, 
the presence of on-site diagnostic, specialized imaging procedures, and interventional 
services, were also related to higher FPM rates.120–122 
Many of the factors associated with high FPM appear to be more prevalent among 
academic medical centers and facilities with National Consortium of Breast Centers 
accreditation or American College of Radiology’s Breast Imaging Center of Excellence 
 
19 
certification.126,127 Yet, Black women are less likely to attend facilities with the 
previously mentioned credentials when compared to White women.128 Recent studies 
have demonstrated that mammography facilities that serve higher percentages of women 
of color have higher FPM rates, even after adjusting for patient characteristics .46,120 
Together, this evidence points to an interplay between Black women’s screening history 
and BrCa screening environments leading to higher levels of FPM results, but the ways in 
which these dynamics impact Black women’s emotions, beliefs, and behaviors around 
BrCa has been left out of research on FPM results. 
2.8 Current Research on False Positive Mammography Outcomes 
2.8.1 Populations Studied 
Studies of this phenomenon begin appearing in the late 1980’s after notable rise in 
mammography screening rates (and preceding a subsequent recommendation for women 
ages 40-49 not to participate in screening mammography).129,130 Multiple reviews of FPM 
studies were published between 1997 and 2010.37,38,131–133 Research on FPM has been 
conducted primarily with homogeneous samples of European women.37,38,43,131,133–144 
Research on the impact of FPM among American women includes samples of primarily 
White, middle to high income, college-educated women.37,38,43 Only a handful of 
American studies include Black women and examine the impact of FPM by 
race.35,43,115,145–155 
2.8.2 Explanatory Mechanisms 
Except for a recent study by DeFrank et al. (2012), none of the previous research 
on this topic tested mechanisms describing how FPM results influence subsequent 
screening behavior as the primary focus has been measuring psychosocial outcomes 
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including anxiety and depression.43,115,131,147–149,151,153,155–157 DeFrank et al. (2012) 
prospectively followed women presenting for mammography to determine how/if 
emotions and BrCa screening beliefs influenced mammography behavior. In this study, 
women with FPM results were more likely to experience delays in the completion of their 
next mammogram and that a mammography recommendation from a provider mediated 
subsequent mammography completion in this group.43 Women receiving a FPM result 
were less likely to complete their next scheduled mammogram, but receiving a 
recommendation from provider reversed this trend.43  
2.8.3 Study Design 
The majority of FPM studies use national or site-based screening cohorts for 
study, but the rarity of FPM results in a given screening year makes the use of a case-
control design a less time and resource intensive option.37,43,158–171 Of the handful of case-
control studies conducted, only one study by Lowe mentions the selection of matching 
controls to create a sample in which demographic characteristics are comparable in 
women with FPM and normal mammography results.115,151,172–177 The lack of unmatched 
case-control studies presents doubts as to the validity of FPM study outcomes as findings 
maybe a result of demographic differences between cases and controls.  
The body of research on FPM results is not without several strengths. An 
important strength is the reliance on prospective studies which confirm a temporal 
relationship between FPM and psychological outcomes.37,43,115,158–168,170,172,173,175,178–181 
Another positive aspect of this work is the vast number of longitudinal studies assessing 
participants shortly after receipt of results and following participants, in some cases, for 
two years after their initial FPM result. 37,43,159–162,164–170,175–178,181 Approximately one-
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third of these studies provide information on the longer term impact of FPM results 
(greater than 6 months after receipt of results) and report differences between women 
with FPM and normal results.37,43,165,166,169,170,175,177,178,181 
2.8.4 Outcomes Assessed 
2.8.4.1 Emotions 
Anxiety was the most commonly assessed outcome across all studies of this 
phenomenon.37,38,131–133 General anxiety was consistently measured with one of three 
standardized measures the Hospital Anxiety and Depression Scale, the Spielberger State-
Trait Anxiety Scale-State Subscale, or the General Health Questionnaire.37,38,182–184 While 
standardized measures have detected higher levels of anxiety among women with FPM 
results, these differences were largely not statistically significant.37,38 On the contrary, a 
substantial number of studies using ad hoc measures of general anxiety report statistically 
significant differences.37,38 BrCa specific-anxiety has been measured by a combination of 
investigator developed measures and the anxiety subscale of the Psychological 
Consequences Questionnaire (PCQ).38,179 The association of elevated levels of BrCa 
specific-anxiety and FPM results persists no matter what assessment was employed.37,38  
Emotions similar to anxiety, including worry, fear, and intrusive thoughts have 
been examined to a much lesser extent and with largely single item questions developed 
for individual studies.37,38 As with BrCa anxiety, measures of worry and fear that are 
specific to breast cancer document higher levels of these emotions among women with 
FPM results.37,38 
 Depression often co-occurs with anxiety and has frequently been assessed in 
studies of FPM mammography.37,38 A wide variety of standardized scales have been used 
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to measure the potential depression among women with FPM results, including:  the 
Hospital Anxiety and Depression Scale, the Hopkins Symptom Checklist, the Depression 
subscale of the General Health Questionnaire, the K-6 Questionnaire, the Beck 
Depression Inventory, and the Short Form of the Center for Epidemiologic Studies 
Depression Scale.37,38,183–188 Yet, the literature on this topic displays a lack of association 
between FPM results and depression.37,38 
 Various aspects of psychological distress and somatization in response to FPM 
results have been documented with mixed results.37,38 Physical, emotional, and social 
distress, as measured by the PCQ, has consistently been associated with FPM status, but 
other scales have not yielded the same results.37,38 There is no clear consensus regarding 
the relationship between physical complaints and FPM status given the different types of 
complaints assessed by each scale.37,38 
2.8.4.2 Breast Cancer Beliefs 
Despite the role of BrCa related beliefs and intentions in understanding BrCa 
screening behavior, less than a third of studies investigate the potential impact of 
receiving a FPM result on BrCa screening beliefs and attitudes.43,112,149,153,163,167,168,178,189–
191 Components of the health belief model have been assessed in various studies with 
perceived BrCa susceptibility being the most frequently examined 
belief.43,149,151,153,163,167,168,191 The impact of perceived susceptibility is inconclusive with 
half the studies measuring this belief reporting statistically significant increases in 
perceived susceptibility among women with FPM results, while the remaining studies 
report no relationship between these variables.43,149,151,153,163,167,168 One study by Molina et 
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al. (2017) revealed the influence of FPM status on perceived susceptibility varied by race, 
with higher levels among Latinas and no differences among White women.191 
Only four studies measured perceived benefits of mammography, but neither used 
a standardized scale.37,43,177,178 DeFrank et al.’s (2012) study of FPM results and 
subsequent mammography behavior found that FPM status was associated with more 
time thinking about the benefits of mammography.43 Gram et al. (1990) and Brett et al. 
(2001) found no association, while Lerman et al. (1991) did not report an analysis of 
these factors.151,177,178 Pisano et al. (1998) and DeFrank et al. (2012) were the only studies 
to examine how the perception of barriers to mammography may vary by mammography 
outcome, and neither detected a statistically significant relationship.43,149 
2.8.4.3 Breast Cancer Screening Intentions and Behavior 
 Screening intention is an important precursor to mammography screening, but this 
concept only been measured in two studies to date.163,192 Lerman et al. (1991) found that 
FPM was associated with increased mammogram screening intention, in contrast to Brett 
et al. (1998) which found no association.163,192 These mixed findings do not extend to the 
impact of FPM results on BrCa screening behaviors. FPM status has overwhelmingly 
been associated with higher rates of breast self-examination rates.37,166,167,169 The impact 
of FPM status on subsequent mammography screening varies by region, with FPM status 
reducing the likelihood of White European women completing mammograms and 
increasing the likelihood of mammography completion among American women.37 FPM 
status did not affect mammography behavior among Canadian women.37 Regional 
differences in the influence of mammography outcomes on future mammography 
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behavior speaks to the influence of additional factors on this relationship, specifically 
health system characteristics.  
2.8.5 Influences on False Positive Mammography Outcomes  
2.8.5.1 Mammography Satisfaction and False Positive Mammography 
Much of the research on mammography satisfaction has been conducted in 
international settings and centers on the influence of patient-level characteristics like age, 
education, and income.89,193 Facility features, such as the patient volume, payer mix, 
geographic location, clinical environment, and provider-level factors, including the 
communication of information about the screening process, and perceived staff 
competence, are described as having an important effect on satisfaction in several 
qualitative studies, but quantitative analyses of these characteristics are limited.194–196 
Both Ong et al. (1997) and Brett et al. (2001) examined how the receipt of FPM results 
relate to mammography satisfaction.158,178 Ong et al.’s (1997) analysis found relationships 
between increased anxiety displayed by women with FPM and poor communication, the 
need for additional information about screening outcomes, and difficulty understanding 
screening results.158 In the case of Brett et al. (2001) no information was given about the 
measure of satisfaction, but incomplete/poor communication about screening results and 
longer wait times were associated with dissatisfaction with the clinical encounter among 
women with FPM results.178 
2.8.5.2 Coping Behaviors and False Positive Mammography 
In the case of BrCa, the majority of studies examine coping in the context of BrCa 
treatment and survivorship, but some research indicates that coping behaviors may also 
play a role in breast cancer screening.197,198 In response to a hypothetical BrCa diagnosis, 
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Black women, White women, and Latinas from multiple countries reported their 
anticipated coping styles in addition to the number of mammograms completed in the 
past 10 years.198 Avoidant coping behaviors were found to be associated with lower 
mammography rates among Black American women, but the direction of this association 
differed within racial groups (Blacks from the Caribbean) and between racial groups 
(Blacks vs Latinas).198 
A single study by Chen et al. (1996) sought to determine the effect of various 
coping behaviors on psychological stress experienced by women with FPM results.180 
Coping strategies appear to be assessed using an early version of the Ways of Coping 
Scale, which measures primary, secondary and tertiary coping responses.180,199 Chen used 
stepwise regression to determine what characteristics mediate/explain the connection 
between FPM results and negative psychosocial outcomes.180 Problem-focus engagement 
behaviors (confronting an issue) were related to lower levels of psychological distress, 
while neuroticism, as measured by Eysenck’s Personality Inventory, was associated with 
higher levels of distress.180 
Conceptualizations of coping behaviors have their roots in the transactional model 
of stress and coping.200 This model stipulates that multiple interdependent processes are 
generated when an individual encounters a stressor.200 In the case of FPM result, the 
characteristics of the event are evaluated during the primary appraisal process, which 
may generate an initial emotional response such as anxiety.200,201 Simultaneously, 
secondary appraisals are employed to determine a course of action, which usually leads to 
a coping response.200,201 Coping strategies can generate new emotions and beliefs in and 
of themselves or through the new appraisals that are generated in response to the coping 
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behavior.200,201 Individual characteristics including personality traits and cultural 
differences in social contexts and emotional expression can greatly impact this process.201  
Personality traits have been shown to impact appraisal outcomes with negative 
traits such as neuroticism leading to potentially less productive avoidant-style coping 
behaviors.202 Additionally, the meaning and usage of coping behaviors vary across racial 
and ethnic groups and in response to different events.203–205 Black American culture has 
retained an emphasis on collectivism, religion, and spirituality thus shaping Black 
women’s coping strategies .203–206 The use of culturally appropriate coping assessments 
such as the Africultural Coping Systems Inventory (ACSI) may be necessary to 
accurately describe Black women’s coping behaviors in the face of a FPM result.204,206 
2.9 Gaps in Research on False Positive Mammography Results 
All of the systematic reviews conducted on this topic have described weakness 
related to measurement and external validity.37,38,131,133 Additional challenges present in 
FPM studies include:  a lack of research on explanatory mechanisms and an 
overemphasis on individual-level factors (to the exclusion of the healthcare 
environment). 
2.9.1 Issues with Study Design and Measurement 
Of the standardized measures that have been consistently used to examine 
anxiety, the following are the most commonly used: Psychosocial Consequences 
Questionnaire (PCQ), Hospital Anxiety and Depression Scale (HADS), General Health 
Questionnaire (GHQ), and the Spielberger State-Trait Anxiety Instrument (STAI). GHQ, 
HADS, STAI are clinical measures and may not be sensitive enough to capture the levels 
of anxiety present during the screening encounter.133 The commonly used measure of 
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BrCa anxiety: the PCQ and the revised version of the measure (PCQ-DK33) have been 
used almost exclusively in European studies, so the psychometric properties of this 
measure with American women is unknown.207 Reliance on cohort designs, self-report 
data, and the small numbers of women with FPM results are methodological limitations 
of this body of work.133 Even more recent work while well designed, uses unstandardized 
measures and/or and has failed to generate mechanisms describing the link between FPM 
results and BrCa screening behaviors .43,115 
2.9.2 Issues with External Validity 
All of the studies mentioned thus far provide important information regarding the 
outcomes of receiving a FPM result, but many of them are not generalizable to American 
populations, including Black women. The impact of FPM on the screening behaviors of 
Black women has been largely ignored as the majority of research on this topic has been 
conducted primarily with homogeneous samples of European women.37,38,43,131,133–144 
Research on the impact of FPM results among American women include primarily 
White, middle to high income, college-educated women.37,38,43 Only a handful of 
American studies include Black women and examine the impact of FPM by 
race.35,43,115,145–155  
2.9.2.1 False Positive Mammography in Black Women and Other Women of Color 
While Black women’s experiences with BrCa screening have been explored in-
depth, only one study has sought to understand how Black women’s screening behaviors 
relate to various screening endpoints such as the receipt of FPM results. Kerner et. al. 
(2003) examined multilevel influences on diagnostic delays in Black women and found 
that women with previous FPMs were 60% more likely to have diagnostic delays than 
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Black women without a history of FPMs.35 Additionally, Black women in this study with 
higher levels of cancer anxiety were less likely to complete their diagnostic follow up 
within the recommended 90 day window.35  
When comparing the effects of FPM in non-White and White women, Gibson et 
al. (2009) found no difference in anxiety levels overall, but upon reviewing outcomes by 
race, non-White women exhibited significantly higher levels of anxiety if they had 
received a FPM result.150 Across racial categories, women in the FPM group with higher 
anxiety scores were more likely to display depressed mood.150 Black women only 
comprised 0.20% of the sample, so it is likely that these results were driven by the Latino 
women in the study.150  
Alderate et al. (2006) reports that Asians were less likely than Whites and Blacks 
to be depressed in the 3-7 months post receipt of FPM result.145 The study also revealed 
that women who reported weekly attendance at religious services during that time were 
less likely to experience depression, but this and other factors correlated with increased 
depression (having a disability) were not examined separately for each racial group.145 
Alderate et al. (2006) also included women whose abnormal results were revealed to be 
malignant, so it is questionable how well this study describes the effects of FPM across 
racial and ethnic groups.145  
While these studies suggest potential negative outcomes of FPM results in Black 
women, with the exception of Kerner et al. (2003), they do not provide insights as to how 
the FPM process may contribute to racial inequities in BrCa screening being that they 
compared the emotional states of Black women to other groups of women as opposed to 
describing the process of and impact of FPM in Black women. Additionally, these studies 
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do not describe the mechanisms by which emotional states, knowledge, attitudes, and 
beliefs influence mammography intention following the receipt of a FPM result in Black 
women.  
2.9.3 Inattention to Mechanisms Explaining the Outcomes of False Positive 
Mammography 
Except for Lidbrink et al. (1995) and Molina et al (2014), none of the previous 
literature on this topic examined what factors mediated psychosocial outcomes of 
receiving FPM results nor have they empirically tested mechanisms connecting various 
psychosocial outcomes of FPM results with future mammography intention.43,115,131,147–
149,151,153,155–157 As psychosocial factors such as emotion, personality traits, and stress 
response are embedded in cultural contexts, it is important to examine the impacts of 
these factors within a specific cultural group in order to explain their effects on health 
behaviors.208 Blacks and members of other more collectivist cultures have been shown to 
rely more heavily on external resources leading to potentially different reactions and 
outcomes than Whites in similar situations.203,206 Incorporating examinations of 
culturally-specific coping strategies, such as the Africultural Coping Systems 
Framework, in response to the receipt of FPM results and can provide important insights 
as to how Black women respond to this phenomenon.206 
2.9.4 Inattention to the Influence of Socioecological Contexts of the Healthcare 
System 
The socioecological model of health describes the influence of intrapersonal, 
interpersonal and system level factors on health outcomes as well as racial inequities in 
cancer screening behaviors.209,210 Patient-level influences on BrCa screening behaviors in 
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Black women are well documented and include:  BrCa knowledge, beliefs and 
attitudes.24,211 In FPM research conducted with US women (primarily White), trait 
anxiety, mood states such as general and BrCa specific anxiety, depression, and coping 
styles have been found to be associated with FPM status.43,115,131,147,148,151,153,155,156 Yet, 
only a handful studies have empirically tested the mechanisms linking psychosocial 
outcomes to mammography screening behavior.43,169,178 
Health system factors shape clinical encounters directly through impacting patient 
experiences and indirectly by shaping provider practice.212,213 Appointment availability, 
referral processes, norms of provider and staff behavior, the method and manner that 
mammography results are communicated, all impact on women’s mammography 
experiences and their satisfaction with these experiences.156,213–215 Facility-level factors 
including but not limited to patient volume, payer mix, facility capacity, can impact 
providers’ behaviors such as the duration and type of communication they are able to 
engage in during a visit.35,213–220 Despite theoretical and empirical knowledge of the 
multilevel influences on mammography and mammography satisfaction, few studies have 
explored these combined influences on mammography or FPM outcomes.215,221 As with 
investigations of FPM outcomes, mammography satisfaction among Black American 
women has received little attention outside of evaluations of patient navigation 
programs.195,222,223 This dissertation research is novel as it employs quantitative and 
qualitative research methods to explore and explain the interaction of various 
socioecological levels during the FPM process and how these factors influenced Black 




2.10 Statement of the Problem 
Black women are less likely to complete the entire BrCa screening process, as 
they are less likely to return when recalled for a mammogram leading to delays in 
diagnosis and treatment.15,16,19,27,83–85,224,225 Understanding what factors influence Black 
women’s behavior during the BrCa screening process can make important contributions 
toward reducing racial inequities in breast cancer burden, yet we do not know how Black 
women’s BrCa screening behaviors are impacted by their experiences with different 
BrCa screening pathways, such as receiving a FPM result. 
The concept of intersectionality along with the frameworks of critical race theory 
and womanism can be applied to this issue to determine how the unique features of Black 
women’s lives shape their health outcomes via their physical and social environments.226–
229 Intersectionality highlights the fact that groups such as Black women face multiple 
intersecting categories of marginalization that shape their life experiences.229 As a result, 
Black women face different barriers due to the way that racism impacts the perceptions of 
their womanhood and vice versa.229 Womanism offers a balance to the concept of 
intersectionality by emphasizing the different sources of strength that Black women can 
tap into as they combat racism, sexism, and other potential sources of 
disenfranchisement.226,230 Critical race theory ties these two perspectives together by 
recommending that studies of health issues in marginalized groups, such as Black 
women, center their experiences and voices, and accounts of the social and cultural 
characteristics that are unique to their lives. 
Black women’s lives are grounded in different healthcare, social, and cultural 
environments leading to differential BrCa risk, incidence and mortality.56 Black women 
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are diagnosed with BrCa at younger ages due to accelerated aging as result of exposure to 
discrimination (the Weathering Hypothesis).231 Additional evidence also links 
discrimination with increased BrCa incidence in Black women.232 Discrimination in the 
form of institutional racism restricts Black women’s access to heath promoting resources 
through residential segregation.233,234 Research indicates that Black women are less likely 
to live near mammography facilities and/or facilities that demonstrate high-quality BrCa 
screening services, which may also impact tumor stage at diagnosis.128,233 Racial 
segregation has also been shown to impact Black women’s mammography follow-up 
times.235 
These challenges do not end once Black women access healthcare facilities. Due 
to historical abuses and past experiences with discrimination, Black women may be 
hesitant to trust providers leading to lower levels of satisfaction and worse healthcare 
outcomes.31,222 Studies of healthcare provider behavior demonstrate the persistence of 
implicit bias and its negative influence on providers’ communication and interactions 
with Black women.59,61,62,236 
In addition to navigating the larger dominant culture, Black women must also 
negotiate Black American culture and its accompanying social and cultural norms. Black 
women’s connection to their communities can function as a source of resources and 
support in times of need, a way to maintain agency during adversity, or a means of 
avoiding or denying unpleasant realities.63,237 The archetype of the “Strong Black 
Woman” allows women to bond through offering help, but it also limits the level to 
which Black woman engage in self-care as they must “be everything to everybody” 
leaving little time for physical and mental health maintenance behaviors.63,237 The strong 
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influence of family and community relationships also has potential implications for 
overcoming the deficits in health promotion resources and knowledge that so many Black 
women must overcome to improve their health.63,237,238 
These features of Black women’s lives underscore the need for research devoted 
to the discovery of deep cultural factors that underlie health and lead to the development 
of culturally competent solutions.65,239,240 Much health research uses primarily White 
populations for theory and intervention development, and the cultural assumptions 
embedded in such work are often not applicable to Blacks.241,242 Increasing racial equity 
in cancer control, and specifically BrCa burden, requires conducting research with Black 
populations to examine the multilevel factors that contribute to racial inequities they 
experience.243 
2.11 Study Purpose  
The purpose of this study was to understand the processes associated with FPM 
results and their impact on BrCa screening intention in Black women using a mixed 
methods study design. This study had two specific aims: 
1) To describe, using a mixed methods approach, the organizational and provider-level 
characteristics of mammography facilities and their impact on Black women’s FPM 
experiences and outcomes. 
2) To determine, through quantitative methods, the relationship between receiving a FPM 
result and future mammography intention among Black women. 
This research has the potential to make significant contributions to cancer 
research by enhancing our knowledge of a common BrCa screening pathway, the one 
ending in a FPM result, and its role in racial inequities in BrCa burden. Several aspects of 
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the research design make this study novel in comparison to other examinations of this 
phenomenon. Empirical data linking organizational, provider, and patient level features 
to BrCa outcomes was generated and used to contextualize the ways in which these 
factors can perpetuate or inhibit racial inequities in cancer burden. The integration of 
relevant behavioral theories such as the transactional model of stress and coping and the 
health belief model will allow for the understanding of the mechanisms responsible for 
the influence of FPM results on subsequent BrCa screening intention. A rigorous study 
design with the use of a case-control study and culturally-appropriate standardized 
measures was used to determine how FPM results influenced Black women’s BrCa 
screening beliefs and attitudes. Previously unknown contributors to delays in diagnostic 
resolution among Black women maybe revealed as a result of this investigation. Given 
the role that diagnostic delay plays in Black women’s increased BrCa mortality, the 






This chapter contains a description of the conceptual model guiding the study. 
Details of the study design, data collection methods, sources, and measures are all 
provided in this chapter. The connections between the conceptual model, specific aims, 
data collected and analyses conducted are also explained in this chapter. The purpose of 
this study was to determine the impact of organizational, provider, and individual-level 
factors on the processes and outcomes associated with FPM results in Black women.  
3.1 Overview of Study Design 
This study had two specific aims: 
1) To describe, using a mixed methods approach, the organizational and provider-
level characteristics of mammography facilities and their impact on Black women’s FPM 
experiences and outcomes. 
2) To determine, through quantitative methods, the relationship between receiving 
a FPM result and future mammography intention among Black women. 
This study consisted of two phases. Phase 1 featured the collection of facility and 
provider level data. Qualitative (observations, key informant interviews) and quantitative 
(medical records review) methods were used to collect data about the organizational 
features of the participating mammography facilities. A quantitative survey tool was 
created and distributed to mammography facility staff members via paper packets, flyers, 
and email messages. Provider demographics, perceptions of women’s mammography and 
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FPM experiences, and providers’ communication about these topics were assessed using 
the survey tool. 
 Phase 2 of the study consisted of the administration of a survey via postal mail to 
a cohort of Black women completing screening mammograms at one of the five 
participating mammography facilities. Cases and controls were selected from medical 
records and sent a packet containing a paper survey and a medical record release form. 
Patient sociodemographic information, mammography experiences, emotional states, and 
coping behaviors were assessed via survey. Medical records were requested for women 
returning a signed release form and used to confirm mammography screening history and 
final screening results. Phase 2 was linked to Phase 1 data and the resulting dataset was 
used to answer research questions for both Phases of the study. 
3.2  Conceptual Model 
This research study was guided by the conceptual model presented in Figure 1. 
The model is based on empirical evidence and components of the multilevel context of 
cancer care model for abnormal mammograms, the transactional model of stress and 
coping, and the health belief model.200,244–246 Figure 3.1 depicts how organizational 
factors directly and indirectly through provider interactions impact women’s 
mammography experiences. Personal characteristics, i.e., race, age, education, shape how 
women interpret their mammography experience (specifically receiving a FPM result) 
and influence their beliefs about the BrCa screening. The relationship between Black 
women’s behavioral beliefs about BrCa screening and their FPM status will be explained 




Figure 3.1 Conceptual Model 
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created by receiving a FPM will shape their beliefs about BrCa screening and 
subsequently their attitude towards completing screening and follow-up procedures in the 
future. Coping strategies will also be generated and will have a moderating effect on 
BrCa behavioral beliefs.  
The multilevel context of cancer care model for abnormal mammograms informs 
the framework by indicating the various levels of influence that impact mammography 
screening behavior: organization/practice setting, healthcare providers, and individual 
patients.244 Study variables are displayed in the conceptual model under their 
corresponding socioecological level. The model describes the various steps from the 
completion of the screening test to initiating diagnostic testing and the referral to 
treatment, if needed. Multiple tasks are required to resolve this process and this model 
describes how factors at the organizational, provider, and individual level can affect the 
successful completion of each task in the follow-up process.  
Each mammography facility has an organizational structure, resources, and 
communication pathways which influence its day-to-day operations. A portion of these 
factors (capacity, patient demographics, patient load, scheduling and notification 
processes) are included in the “Organization/Practice Setting” section of the conceptual 
model. Mammography facilities have a direct impact Black women’s mammography 
experiences through system level factors and indirectly through health providers. 
Through their training, communication behaviors, attitudes towards 
mammography, and their perceptions of patient’s mammography experiences; healthcare 
providers impact women’s clinical encounters just as healthcare providers are impacted 
by the organizational structures of their workplaces. Mammography and primary care 
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providers influence Black women’s mammography experiences through similar factors, 
but primary care providers also have the responsibility of recommending mammography 
screening. Healthcare providers’ characteristics are listed by provider type under the 
“Healthcare Provider” heading in the conceptual model. 
Relationships between several individual patient characteristics are displayed in 
the “Individual Patient” section of the conceptual model. A variety of individual level 
factors interact to shape how women perceive the mammography experience and their 
responses to that experience. Demographic characteristics, such as age, education, marital 
status, employment status, income, and health insurance status impact not only where 
women access BrCa screening services, but how they are treated during the clinical 
encounter. Other factors such as the presence of an anxious personality and/or levels of 
social support can shape how women react to the mammography experience. A woman’s 
BrCa screening history and her previous experience with receiving a FPM results are 
additional factors that will impact her perception of her current mammography 
experience and thus impact her beliefs about mammography, BrCa screening, and cancer 
prevention, in general. It is these BrCa related beliefs that impact a woman’s intention to 
complete future screening procedures and/or follow-up on future inconclusive results. A 
reduction in mammography intention will lead to lower rates of initial mammography 
screening and mammography follow-up. Delays in diagnosis and detection can lead to 
increased rates of advanced stage BrCa and BrCa mortality. 
The relationship between a woman’s perception of the mammography experience 
and her beliefs about BrCa screening/mammography may vary by her reaction to the 
mammography experience (receiving a FPM result). The transactional model of stress 
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and coping states that people complete primary and secondary appraisals which inform 
the actions they take when confronted with stressful events.200,201,245  
 Primary appraisal generates emotions, but the types of emotions generated depend 
on the features of the event.201 Receiving a FPM result is an external event that is 
relevant, significant, and uncontrollable, which are characteristics typically lead to fear 
and/or anxiety.201 A secondary appraisal takes place where the individual adopts a coping 
strategy to deal with the event.200,245 While the appraisal process is described in a linear 
fashion, in practice is it not.200,201 As new information is obtained new appraisals are 
made, new emotions are generated, and new coping behaviors maybe adopted.200,201 
Additionally, coping behaviors can influence new appraisals and beliefs related to the 
event in question.200,201 In the context of FPM results, new appraisals maybe be generated 
at each point in the process, the employment of coping behaviors has the potential to 
change a women’s attitude toward the behavior (benefits and barriers to mammography) 
and her susceptibility to BrCa. These constructs of the health belief model have been 
shown to impact future mammography intention in Black women, thus if FPM impacts 
mammography intention it likely through these beliefs.88,189,247  
3.3 Specific Aim 1  
To describe, using a mixed methods approach, the organizational and provider-
level characteristics of mammography facilities and their impact on Black women’s FPM 
experiences and outcomes. 
Research Question 1.1. What organizational, provider, and patient-level 
characteristics predict high levels of satisfaction with their clinical encounter among 
Black women experiencing a FPM result? 
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Hypothesis 1.1. Mammography facilities with lower screening capacities, higher 
diagnostic capacity, which employ more patient management systems, have fewer 
“patient friendly features” in their clinical environments, and have more providers 
reporting low perceptions of women’s distress about FPM will lead to higher levels of 
satisfaction with the clinical encounter among Black women experiencing a FPM result. 
3.3.1 Setting 
This research study was conducted in collaboration a leading provider of 
mammography services in the Columbia, SC MSA which diagnoses roughly 70% of the 
total BrCa population in the area.79 The Columbia, SC MSA consists of the city of 
Columbia and its surrounding counties with an estimated population of 776,794 (of 
which 66,358 were Black women over the age of 35) in 2013.248 Screening 
mammography is offered in four in ambulatory care centers and via a mobile 
mammography van servicing communities across the state (See Figure 3.2).  
Between June 2013 and June 2014, 38,500 women completed screening mammograms in 
the health system. Across the system, 2,456 (6.3%) women were recalled for additional 
follow-up testing, and 248 women were diagnosed with cancer. Approximately 30% of 
women with FPM results were Black, 29% were in the 40-49 age range, 36% were in the 
50-64 age range, and 16% were 65 and older. A little over 50% of women completing 
screening mammograms lived within the city of Columbia, and 90% of them resided in 
the Columbia MSA. 
3.3.2 Data Sources and Collection Methods  





Figure 3.2 Locations of Participating Mammography Facilities in Richland County, South Carolina 
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February 22, 2016 and the Palmetto Health Administrative Review approval was granted 
on February 26, 2016 (See Appendix A). Participant observations, key information 
interviews, provider surveys, and screening record reviews were conducted during Phase 
I. Participant observations and key informant interviews began March 2016 and 
concluded August 2016. Provider surveys were fielded from April 2016 to August 2016. 
Screening records were collected from June 2016 through October 2016. Organizational 
measures and provider survey domains are presented in Figures 3.4 and 3.5. The 
variables incorporated in Phase I analyses and the methods used to collect this data are 
described below. 
Observations. Patient and clinical settings were observed at each mammography 
facility for one to three hour sessions to capture information about each facility’s 
processes and procedures. Observations were unstructured. Patient-provider, patient-
patient, and provider-provider interactions were recorded during observations. 
Descriptions of the physical surroundings were also captured during observations. Times 
and locations (waiting rooms vs clinical care areas) were rotated to gain a comprehensive 
view of site procedures. Observations were recorded via handwritten or electronic notes. 
Observation notes were manually transcribed and imported along with electronic notes to 
NVivo 11. 
Key informant interviews. Interviews were conducted with imaging supervisors 
and coordinators at each mammography facility to collect information about facility 
characteristics such as reporting structure, equipment, staffing, notification procedures, 














interview form (See Appendix B) and the resulting information was recorded in a 
Microsoft Excel spreadsheet. 
Retrospective mammography screening data. Demographic information (date 
of birth, race, health insurance product and zip code) and mammography screening 
outcomes (procedure, procedure date, procedure type, BI-RADS rating, and facility) for 
women completing screening mammograms from January 2016 to August 2016 were 
requested from the Palmetto Health Radiology Department on a monthly basis. Data was 
imported into STATA 13 for data management and analysis. Visits were matched 
medical record number to create a visit history for each patient. Data were analyzed in 
aggregate to generate facility characteristics such as patient volume, and patient 
demographics.  
Mammography provider surveys. Physicians and staff members at all 5 
facilities (n=46) were asked to complete a survey about their experiences with 
mammography screening and their perceptions of women’s mammography experiences 
(See Appendix C). All individuals designated as having patient contact and who worked 
in a Palmetto Health mammography facility for at least six months prior to the start of the 
study were eligible to participate in the survey. Participants were recruited using e-mail, 
flyers, word of mouth, and project presentations at staff meetings. Survey participants 
were entered into a giveaway to receive one of 10 $25 gift cards after the survey was 
concluded.  
The survey consisted of closed and open-ended items assessing demographic 
information (age, gender, race, provider type, professional training) and providers’ 
perceptions of patients’ physical and psychological comfort used by Nutting et. al. (2001) 
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during their evaluation of influences on primary care providers.213 Items from national 
surveys of provider communication regarding dementia and aging and studies of genetic 
counselors’ communication with patients of different were adapted to assess 
communication from the providers’ perspectives.249–251 These items assessed providers’ 
perceptions of the FPM experience and how providers communicate about this 
experience. Staff members completed surveys online or using paper survey packets that 
were returned via postal mail. Survey results were imported into STATA 13 and NVivo 
11 for interpretation. 
3.3.3 Data Management  
A data dictionary was developed, and the facility data (observation, key informant 
interview, medical records, and provider survey data) were entered into a password 
protected spreadsheet using numeric codes. Data for each site were entered using an 
identification number. The data file was uploaded into STATA 13 and merged by site 
with the patient survey data collected in Phase 2. All notebooks and paper surveys were 
stored in a locked file cabinet in a locked office at the University of South Carolina. All 
electronic files were stored on password protected laptop in a locked office at the 
University of South Carolina.  
3.3.4 Data Analysis  
All organizational and provider variables were numerically coded and entered into 
spreadsheet and analyzed in STATA 13.252 Means and frequencies for organizational and 
provider level measures were calculated and chi-square tests and ANOVA were used to 
detect any statistically significant differences in organizational and provider 
characteristics between sites. Mean values for patient volume, the number of privately   
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insured patients, non-White patients, hours of operations, screening procedures and 
diagnostic were calculated and used as a cut point to categorize facilities as high or low 
for each variable. Features of the clinical environment such as a dedicated waiting room 
for follow-up patients, the presence of educational materials, screening navigation, 
outreach activities, and free parking were marked as present or absent. Providers’ 
responses regarding their perceptions of patient’s physical discomfort, psychological 
discomfort, and distress about screening and FPM were averaged for each facility.  
Associations between organizational, provider level data, and patient satisfaction 
data collected in Phase 2 were assessed using linear regression for continuous variables 
and ANOVA for categorical variables. The primary analysis for Specific Aim 1 consisted 
of bivariate logistic regression models to determine the influence of facility, provider, and 
patient characteristics on satisfaction with mammography by mammography outcome 
(FPM status vs. normal).  
3.4 Specific Aim 2 
To determine, through quantitative methods, the relationship between receiving a 
FPM result and future mammography intention among Black women. 
Research Question 2.1. What is the relationship between receiving a FPM result 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) among Black women? 
Hypothesis 2.1. Receiving a FPM result will have an overall negative effect on 
BrCa behavioral beliefs in Black women. Specifically, Black women with a FPM result 
will report lower levels of perceived mammography benefits, higher levels of perceived 
mammography barriers, and higher levels of perceived BrCa susceptibility.  
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Research Question 2.1.a. Do Black women’s emotional states explain the 
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of 
mammography, perceived BrCa susceptibility, and perceived barriers to mammography 
screening)? 
Hypothesis 2.1.a. Anxiety and depression will each independently explain the 
relationship between receipt of FPM results and BrCa behavioral beliefs. 
Research Question 2.1.b. Does the relationship between receipt of FPM results 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) vary by coping 
strategy employed? 
For Black women with FPM results, women engaging in high levels of 
cognitive/emotional, collective, and spiritual coping behaviors will have a positive effect 
on BrCa behavioral beliefs. Specifically, Black women with FPM results who engage in 
high levels of cognitive/emotional, collective, and spiritual coping behaviors will report 
higher levels of perceived mammography benefits, lower levels of perceived 
mammography barriers, and lower levels of perceived BrCa susceptibility. 
Research Question 2.2. What is the relationship between BrCa behavioral beliefs 
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived 
barriers to mammography screening) and intention to complete future mammography 
screening? 
 Black women reporting high levels of perceived benefits of mammography, low 
levels of perceived barriers to mammography, and high levels of perceived BrCa 
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susceptibility will display increased intention to complete future mammography 
screening. 
3.4.1 Study Design  
 A survey was designed and fielded to collect data from women completing 
screening mammograms for Phase 2 (See Appendix D). Given the low number of women 
in the population with the desired characteristic (FPM represented 6% of the screening 
patients between June 2013 and July 2014) a case-control study design was employed to 
maximize the number of participants with FPM results. Black women aged 40 and older 
(evidence indicates that many women were still following the American Cancer Society’s 
pre-2015 BrCa screening guidelines and were completing screening mammograms 
between the ages of 40-45),253 BrCa free for 5 years or more, no evidence of serious 
mental illness, and whose final mammography results were confirmed as benign were 
eligible to participate. Patient survey participants were entered into a separate giveaway 
for a chance to win one of 10 $25 gift cards at the conclusion of Phase 2. 
3.4.1.1 Sampling 
 Women whose screening mammograms were classified as BI-RADS Category 0 
were selected as cases.39 A control participant was selected from eligible women whose 
screening mammogram was classified as BI-RADS Category 1 (Negative) or Category 2 
(Benign) and occurred on the same day and at the same facility as her matched case.39 
3.4.1.2 Sample Size  
 Only a few US studies have examined the impact of FPM results on future 
mammography intention/behavior and they reported small (OR Range: 0.42 - 1.50) to 
medium effect sizes (OR 2.12, CI:1.54 -2.93).43,115,147,148,155 With α=0.05, power = 0.80, 
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and model with 10 predictors, a sample size of 1,064 would be required to detect a small 
effect size and 157 (case and control) participants to detect a medium effect size as 
calculated by G*Power.254 Estimating that 20% of surveys will have missing data, a final 
sample size of 188 will be needed answer Specific Aim 2.  
3.4.1.3 Measures  
 A 177-item survey tool was used to assess patient demographic information, 
previous BrCa screening history, and psychosocial constructs. Domains and scales 
included in the patient surveys tool are listed in Figure 3.5. Information describing the 
index screening mammogram was collected via survey and compared to the medical 
record to ensure accuracy. Measures analyzed for Phase II are described in detail below. 
Demographics – Demographic items such as age, education, employment status, 
income, marital status, and health insurance status were modeled after items used in the 
National Health Interview Survey and the Behavioral Risk Factor Surveillance 
Survey.255,256  
Breast Cancer Screening History – Items assessing age at initiation of 
mammography screening, the receipt of a provider’s recommendation for mammography, 
family history of BrCa, and FPM mammography history were used to collect information 
about participants’ BrCa screening history. These items were modeled after items from 
the National Health Interview Survey.255 
Interpersonal Personal Processes of Care Survey: Discrimination and 
Disrespectful office staff subscales – The scale measures aspects of provider 





Figure 3.5 Patient Survey Measures 
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of discrimination and disrespect during clinical encounters were assessed with the 
discrimination and disrespectful office staff subscales, respectively. Validation samples 
included multiple racial and ethnic groups, the reliability coefficients for the 
Discrimination subscale is 0.79 and for the Disrespectful office staff subscale is 0.90.257 
Spielberger State-Trait Anxiety Inventory (STAI): Trait and State Short 
Scales – A 10-item scale which measures anxiety as a personality trait and another 10-
item scale that measures the anxious emotional states. The scale has been validated in a 
variety of populations with good reliability (α=0.86 to 0.95).182 
CES-D Short Form – This 10-item survey has been validated with many 
populations around the world and measures subclinical levels of depression. The short 
form has good internal consistency (α=0.75).185 
Africultural Coping System Inventory – An African cultural framework guided 
this 30-item measure which assesses the use of four coping strategies used by Blacks in 
response to a stressful event. The reliability coefficients for the four subscales range from 
0.76 to 0.82.206 
Champion Attitudes Towards Mammography and Breast Cancer Scale: 
Mammography Benefits, Susceptibility and Barriers Subscales – The four-item 
Benefits sub-scale is part of a larger scale that examines Black women’s attitudes and 
beliefs toward BrCa screening. The four item Susceptibility sub-scale measures 
susceptibility to BrCa and is highly reliable (α=0.73).258 The scale’s internal consistency 
is adequate (α= 0.73).258 A shortened 10-item version of the original 19 item barriers 
subscale was used assess various logistical challenges associated with mammography.258 
The original subscale is highly reliable (α=0.89).258 
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Cockburn’s Mammography Satisfaction Scale – This 26-item scale was 
developed in Australia to measure women’s satisfaction with their mammography 
experiences. The scale has six subscales that measure different aspects of satisfaction: 
general, convenience and accessibility, provider information transfer, staff interpersonal 
skill, physical surroundings, and perceived technical competence.179 The reliability 
coefficients for the original scale were low (0.53-0.68), but a modified version has been 
used with an American population with good results.207 
Psychological Consequences Questionnaire DK-33: Anxiety Subscale (PCQ-
DK33) – The revised version of Cockburn’s Psychological Consequences Questionnaire 
contains 33 items which measures women’s psychological responses to screening 
mammograms.259 One of these domains, anxiety, is measured with a six item subscale 
that has been found to be highly reliable in Danish women (α=0.92), but its use in 
American samples is limited.259 
Mammography intention – This variable was measured using two ad hoc items: 
1) How likely are you get your next screening mammogram as scheduled? and 2) If you 
asked to return for follow-up testing after your next screening mammogram, how likely 
are you to complete those additional tests? Response categories were 1=Very Unlikely, 
2=Unlikely, 3=Likely, and 4=Very Likely. 
3.4.14 Survey Administration  
Packets containing surveys, medical records release forms, pre-addressed postage-
paid envelopes were mailed to eligible patients six months after their initial screening 
mammograms to allow for the completion of follow-up testing (July 2016-January 2017). 
Reminder letters were sent to participants one month after the mailing of the initial 
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survey packet and one month prior to the scheduled end date for the patient survey. 
Participants were provided an option to complete the survey over the phone or to call the 
principal investigator to recieve get more information about the study. Brief summary 
sheets with study contact information were distributed to Palmetto Health staff members 
as a reference if women inquired about the study. Medical records were used to confirm 
BrCa screening history information and final screening outcomes reported via survey. In 
total, 909 survey packets were mailed (411 cases, 498 controls), 25 surveys were returned 
to sender, two were found to be ineligible and did not return surveys. Of the remaining 
882 surveys distributed, 133 (15.0%) were returned.  
 Pilot Testing. Surveys were pilot tested in two waves during June 2016. In total, 
seven Black women aged 35 and older completed the survey. The first wave consisted of 
three members of the research staff, two of whom had previously completed screening 
mammograms. After incorporating the feedback from the first wave, the principal 
investigator recruited 5 Black women who meet the eligibility criteria, but lived outside 
of the Columbia, SC MSA for the second wave. A full-scale pilot was conducted with 
survey packets being mailed to participants in the second wave. Additional edits were 
made to the survey tool based on the data collected during the second wave.  
3.4.2 Data Management 
 Each survey packet was assigned a participant id which was attached to all survey 
materials. All surveys, medical record release forms, and medical records were tracked in 
a password protected Microsoft Excel spreadsheet. Survey responses were coded using a 
data dictionary and manually entered by participant id into a separate password protected 
Microsoft Excel spreadsheet. The data file was uploaded into STATA 13. Paper surveys,   
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medical records, and medical records release forms were stored in a locked file cabinet in 
a locked office at the University of South Carolina. Medical records were destroyed using 
secure data handling procedures after the extraction of required data. All electronic files 
were stored on password protected laptop in a locked office at the University of South 
Carolina.  
3.4.3 Data Analysis  
All patient level variables were analyzed in STATA 13. Means and frequencies 
were calculated for all variables. Chi Square tests and ANOVA as appropriate were used 
determine associations between demographic variables, BrCa screening history, trait 
anxiety, state anxiety, BrCa-specific anxiety, depression, coping strategies, perceived 
mammography benefits, perceived mammography barriers, perceived BrCa susceptibility 
and FPM status. Specific analyses for each research question included in Specific Aim 2 
are described below. 
Research Question 2.1. What is the relationship between receiving a FPM result 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) among Black women? 
Covariates associated with BrCa behavioral beliefs and FPM were used to guide 
the construction of ordinary least squares regression (OLS) models developed to address 
this research question. OLS models assessing the relationship between each BrCa 
behavioral belief (perceived mammography benefits, perceived mammography barriers, 
perceived BrCa susceptibility) and FPM status were constructed, and theoretically 
important variables expected to influence each BrCa behavioral belief were included in 
the model for that belief (e.g. family history of BrCa was included in the model for 
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perceived benefits and susceptibility to BrCa). Mean values of BrCa behavioral beliefs 
for women with FPM and normal mammography results were calculated using the 
average values for the sample with the margins command in STATA. Multilevel 
variables such as age category or health insurance status were tested for significance 
using the Bonferroni adjustment. 
Research Question 2.1.a. Do Black women’s emotional states explain the 
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of 
mammography, perceived BrCa susceptibility, and perceived barriers to mammography 
screening)? 
For OLS models constructed in Research Question 2.1 that were statistically 
significant, state anxiety, BrCa specific anxiety, and depression were tested as mediators 
using the khb command in STATA. Trait anxiety appeared to function as mediator in 
preliminary tests; thus it was included in mediation analyses.  
Research Question 2.1.b. Does the relationship between receipt of FPM results 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) vary by coping 
strategy among Black women? 
For OLS models constructed in Research Question 2.1 that were statistically 
significant, coping behaviors were tested as moderators. Interaction terms were created 
by centering each variable at the mean value for the sample and incorporating a term into 
the model containing the coping style and FPM status. Mean values for BrCa behavioral 
beliefs at each level of coping style were calculated using the margins command in 
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STATA. These values were plotted and used to determine the presence of effect 
modification. 
Research Question 2.2. What is the relationship between BrCa behavioral beliefs 
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived 
barriers to mammography screening) and intention to complete future mammography 
screening? 
Associations between BrCa behavioral beliefs, FPM, mammography screening 
intention, and follow-up intention were used to guide the construction of ordinary least 
squares regression (OLS) models developed to address this research question. OLS 
models assessing the relationship between each BrCa behavioral belief (perceived 
mammography benefits, perceived mammography barriers, perceived BrCa 
susceptibility) and mammography intention (screening and follow-up) were constructed. 
FPM status and theoretically important variables expected to influence each BrCa 
behavioral belief were included in the model describing the relationship between that 
belief and mammography intention (screening and follow-up). The mean values for 
mammography intention (screening and follow-up) for women with FPM and normal 
mammography results were calculated using the average values for the sample with the 
margins command in STATA. Multilevel variables such as age category or health 







 This chapter contains the results of the research conducted to examine the 
influence of multilevel factors on Black women’s experiences with FPM results and the 
impact of that experience on intention to complete future BrCa screening and diagnostic 
testing. Manuscript 1 addresses Specific Aim 1, by answering Research Question 1, 
through the analysis of the influence of organizational, provider, and patient-level data on 
mammography satisfaction among Black women. Manuscript one has been prepared for 
submission to the journal Medical Care. Specific Aim 2 and its composite research 
questions are described and answered in Manuscript 2. The relationship between FPM 
status, BrCa behavioral beliefs, and mammography intentions is explored in Manuscript 
2, which will be submitted to the American Journal of Preventive Medicine.   
 
1Farr DE, Brandt HM, Friedman DB, Armstead C, Adams SA, Fulton J, Bull D. To be 
submitted to Medical Care 
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4.1 Contributions of Mammography Facility, Provider, and Patient Characteristics on 




Background. Black women are less likely to complete mammography screening. Prior 
screening experiences such as the receipt of false positive mammography (FPM) results 
may influence Black women’s satisfaction with their clinical experience and subsequent 
desire to complete future screening. Objectives. The purpose of the study is to 
understand which facility (environmental), provider, and patient level factors influenced 
aspects of satisfaction with the mammography screening experience among Black women 
and if FPM status altered these relationships. Research Design. A case-control study was 
conducted using observations, medical record data, and surveys. Logistic regression 
models were developed to determine influences on different aspects of mammography 
satisfaction. Subjects. Participants included mammography facility staff, and Black, 
cancer-free mammography patients aged 40 and older who completed index 
mammograms between January and August 2016. Measures. The Cockburn 
Mammography Satisfaction Scale, which contains six subscales, was the main outcome 
measure. Results. No facility, provider or patient factors were associated with two types 
of satisfaction: general and provider interpersonal style. FPM status was one of several 
patient characteristics associated with lower level of satisfaction with convenience and 
provider information communication. Facility and provider level factors had negative and 
positive effects on satisfaction with provider competence. Satisfaction with the clinical 
environment was also influenced by facility characteristics. Conclusions. Varied aspects 
of the clinical encounter influenced Black women’s satisfaction with their mammography 
screening experiences. Further research is needed to understand how these clinical 
encounters contribute to future screening and diagnostic delay in this population. 
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Keywords: (3-5) Mammography, False Positive, African American, Patient 
Satisfaction, Female 
Introduction 
Black women have experienced disproportionately high rates of breast cancer 
(BRCA) mortality for the past three decades.1 A complex mix of biological, cultural, 
economic, and healthcare-related factors contribute to this racial inequity.1 Healthcare-
related factors are critical as they have the potential to impact BRCA stage at diagnosis 
through their influence on the timely resolution of abnormal mammography results.2 
Delays in mammography follow-up among Black women have been extensively 
documented and largely attributed to lower levels of BRCA knowledge and healthcare 
access in this population.3,4 The role of Black women's past mammography experiences is 
largely absent from research on screening and diagnostic delays. Some evidence indicates 
that past false positive mammography results may influence Black women's decisions to 
complete follow-up testing after receiving abnormal results.5,6 
False positive mammograms (FPM) are defined as abnormal screening mammograms 
that are later confirmed as non-cancerous.7 Studies have link FPM with psychosocial 
outcomes (e.g. anxiety, depression), BRCA related-beliefs (e.g. BRCA risk, screening 
effectiveness, screening intention), and screening behaviors, but the relationship between 
FPM and women’s satisfaction with the mammography process has largely been 
ignored.7,8 Patient satisfaction has been associated with mammography completion across 
diverse populations, but it is unclear how (or if) the process of completing diagnostic 
testing influences women's satisfaction with the screening process.9–11 Limited evidence 
indicates that satisfaction with aspects of the screening process, such as patient-provider 
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communication and quality of care, may differentially impact women who are asked to 
return for additional testing.5,12–14 Satisfaction with prior screening encounters among 
women with FPM status may influence BRCA screening attitudes and future screening 
behavior in this group of women.  
Much of the research on mammography satisfaction has been conducted mainly in 
Europe and centers on the influence of patient-level characteristics, such as age, 
education, and income.15,16 Facility (or environmental) features, such as the patient 
volume, payer mix, geographic location, clinical environment, and provider-level factors, 
including the communication of information about the screening process, and perceived 
staff competence, are described as having an important effect on satisfaction in several 
qualitative studies, but quantitative analyses of these characteristics are limited.17–19 As 
with investigations of FPM outcomes, mammography satisfaction among Black 
American women has received little attention outside of evaluations of patient navigation 
programs which seek to support women in the completion of the BRCA screening 
process.18,20,21 
Given the persistence of mammography delays among Black women, the impact of 
facility features, provider interactions, and patient characteristics on Black women's 
experiences with FPM and effect on mammography satisfaction warrant exploration. The 
purpose of this study was to determine what facility, provider, and patient-level 
characteristics predicted high levels of satisfaction among Black women and whether the 
factors associated with satisfaction vary by FPM status. Previous studies suggest that 
characteristics which many enhance patient-communication and reduce logistical barriers 
to screening will be associated with higher levels of mammography satisfaction. 
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Specifically, mammography facilities with low screening capacities, with screening and 
diagnostic capacity, and more “patient friendly features” in their clinical environments, 
and mammography providers who are more sensitive to the distress or discomfort of 
women experiencing a FPM will lead to a higher level of mammography satisfaction. 
Patients with normal screening results, higher education levels, higher income, and of 
older age will be more satisfied with their mammography experience. 
Methods 
Setting. Study data were collected from five mammography facilities affiliated with a 
large hospital system located in the Midlands region of South Carolina. Study activities 
were approved by the Palmetto Health Institutional Review Board. 
Data Collection. Data collection began in March 2016 and concluded in January 
2017. Information about the physical characteristics of and operating procedures at each 
facility were collected through key informant interviews and observations. Key informant 
interviews were conducted with a supervising staff member at each facility A structured 
interview guide with items assessing organizational structure, services offered, clinical, 
and notification processes, and the physical environment was used during the interview. 
Unstructured observations were conducted to examine clinical processes and determine if 
any processes changed during the study period. Observation and interview data were 
manually coded by site and entered into a spreadsheet for organization and analysis. 
De-identified clinical records were collected for women completing screening 
mammograms between January and August 2016. Clinical records provided patient 
demographic information (age, race, health insurance product, and zip code) and 
mammography screening information (procedure, procedure date, procedure type, BI-
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RADS rating, and facility) for patients screened during that timeframe. All women with 
current or previous breast cancer diagnoses were removed from the analysis to examine 
influences on satisfaction in the average risk screening population. Patients were grouped 
by the facility where they completed their index mammogram, and demographic 
characteristics of the patient population were calculated for each facility.  
Provider surveys were distributed to clinical and administrative staff at the 
mammography facilities via paper packets and online links. Only individuals employed 
by a mammography facility for at least six months were eligible to complete the survey. 
Surveys were distributed via paper packet during staff meetings and via e-mail to key 
staff members. Approximately 40 individuals were eligible for this portion of the study, 
and 24 staff members returned the survey for a 60% return rate. Staff members’ age, 
gender, race, job title, and education level were collected in addition to questions 
examining providers’ clinical experiences. Items assessing perceptions of women’s 
experiences with mammography and FPM status were modeled after questions used to 
examine primary care providers ratings of patients physical and psychological comfort.22 
Survey responses were attributed to the facility (or facilities) where each provider 
practiced.  
Patients meeting the following criteria were eligible for participation:  Black/African 
American, aged 40 or older, BRCA free for five years or more, and completed index 
screening mammograms between January and August 2016. Survey packets were sent to 
potential study participants approximately six months after their index mammogram. 
They received reminders one month after the initial mailing and prior to the conclusion of 
the study. A case-control design was employed to ensure the recruitment of sufficient 
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numbers of women with FPM results. Women whose index mammogram had a Breast 
Imaging Reporting and Data System (B-IRADS) classification of 0 were designated as 
FPM. Each FPM was matched to a woman who completed an index mammogram at the 
same facility on the same day, but whose final result was BI-RADS 1 or 2. Packets 
contained medical records release forms and a paper survey tool. Separate gift card 
giveaways were held for participants completing provider and patient surveys to 
acknowledge their efforts. 
In total, 909 survey packets were mailed to patients with 25 returned due to bad 
addresses and two did not meet the racial eligibility criteria. Of the remaining 882 
surveys distributed, 133 (15.0%) were returned. Of the surveys returned, five were 
ineligible due to recent BrCa diagnoses or serious mental illness and 11 were excluded 
from analyses due to missing demographic information or conflicting responses. A final 
sample of 117 patient surveys were included this analysis.  
 Patient Survey Measures. Questions from the National Health Interview Survey 
were used to collect information about patient age, education, marital status, and family 
history of breast cancer.23 Patient age was calculated using date of birth and collapsed 
down to three categories 40-49, 50-64, 65 and older. Education was dichotomized into 
either less than a college degree or a college degree or higher. Marital status was 
collected as married, living with a partner, widowed, divorced, separated, and single 
(never married). Married and living with a partner were reclassified as partnered and the 
remaining categories were named unpartnered. Zip code, health insurance status, and 
screening facility were obtained from patient medical records. Zip codes were mapped to 
counties which were subsequently classified as urban or rural.24 Health insurance 
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products were classified as private or public using information from the South Carolina 
Department of Health and Human Services website and the National Committee for 
Quality Assurance Health Insurance Plan Ratings 2016-2017.25,26 
Patient-provider interactions were measured using the discrimination and 
disrespectful office staff subscales of the Interpersonal Processes of Care Survey.27 The 
scale measures provider communication factors that were indicated to be important by 
Blacks and other people of color27 The Discrimination subscale consists of two items that 
assess perceptions of discrimination the clinical encounter.27 Four items such as “How 
often did office staff talk down to you?” compose the Disrespectful office subscale.27 
Responses for both subscales were measured on a 4-point scale with 1 = Never and 4 = 
Always.27 Scores were computed by averaging responses. Both subscale scales 
demonstrated sufficient reliability in this sample, with α of 0.63 and 0.71 respectively.  
Satisfaction with the mammography experience was measured with the Cockburn 
Mammography Satisfaction Scale which contains the following subscales: general, 
convenience and accessibility, provider interpersonal skills, provider information 
communication, physical surroundings, perceived provider competence.28 Each subscale 
contains 4 to 5 items measured on a 4-point scale with 1 = Strongly Disagree and 4 = 
Strongly Agree.28 Satisfaction scores were generated by summing all responses after 
reverse coding negatively worded items. Except for the provider information transfer 
scale (α=0.53), all subscales had adequate internal consistency in this survey population 
with reliability coefficients ranging from 0.62 to 0.73.  
Data Analysis. Facility information and provider survey data were linked to patient 
survey responses by screening site. Descriptive statistics (proportions and means) were 
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calculated for facility and provider characteristics by site, entered into a spreadsheet, and 
merged with patient survey data. Chi-square tests and ANOVA were used to detect site 
level differences in characteristics. Multivariable models were constructed to examine the 
impact of multilevel characteristics (facility, provider, and individual) on the domains of 
mammography satisfaction. As two of the five facilities accounted for the majority of 
data, the lack of variability in the sample prevented the creation of stable multivariable 
models containing all three levels of data. Bivariable logistic regression models were 
used to examine the relationship between factors that would influence the aspect of 
satisfaction examined taking account FPM status (e.g. provider communication variables 
were not included in models for satisfaction with convenience or the physical 
environment). All data analyses were conducted using STATA 13 and statistical 
significance was evaluated using an alpha of 0.05.29  
Results 
 Facility Characteristics. Descriptive information for the patient population of the 
five mammography facilities is presented in Table 1. Over 25,000 procedures were 
completed between January and August 2016 at all sites combined, and the majority of 
these procedures were screening mammograms (89%). Site A was the largest site, and it 
served a higher percentage of women over the age of 65 and women with public health 
insurance. While Site A had equal amounts of White and non-White patients, Site B 
similarly had a higher proportion of Black patients specifically (57.6%) and non-White 
patients overall (61.8%). In contrast to Sites A and B, Site C is based in a suburban area 
and has an increased proportion of older (38.2%), White (75.5%), rural (6.7%), and 
privately insured (53.7%) patients. Both screening and diagnostic services were offered at 
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Sites A, B, and C, however, Site C offered fewer diagnostic hours per week requiring 
patients to wait to complete follow-up testing at Site C or seek care at Sites A or B. As 
larger sites, Sites A and B had separate waiting rooms for diagnostic visits and several 
exam rooms. Only Site B had internally developed print educational materials about 
breast cancer screening available in the main waiting room for women to review. The 
remaining sites only provided screening services, and women who required follow-up 
were referred to one of the diagnostic sites. Site E represents a mobile mammography 
unit that provides services to various institutions across the state (mostly worksites and 
community groups). Thus, a much higher number of women completing screening at Site 
E were under age 65 (83.4%), White (62.9%), lived in rural areas (15.5%), and had 
private health insurance (74.5%).  
 Provider Characteristics. Twenty-four staff members completed the provider 
surveys (demographic data not displayed due having less than 5 observations at some 
sites). Responses for staff members who worked at more than one facility were included 
in each of their worksites. Provider characteristics were similar across sites with the 
majority of respondents being in the 40-60 age range (mean age 47.9 ± 8.91), female 
(91.7%), and White (87.5%). All respondents had some elements of patient contact as 
part of their responsibilities whether they were radiologists, mammographers or 
imagining technicians who perform screening procedures, or patient care 
technicians/coordinators who provide instructions and facilitate many aspects of the 
clinical encounter. Most respondents had less than a bachelor's degree (70.8%) as 
imaging and patient care positions require certification provided by a relevant training 
programs. On average, respondents had worked 23.3 years in the healthcare field.   
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Across sites, staff members had similar perceptions of women's mammography 
encounters (Table 2). Providers reported that women experienced some physical 
discomfort (sample mean = 2.5) and psychological distress (sample mean = 2.5) during 
the mammography procedure. When asked specifically about women's reactions to 
mammography follow-up, most staff responded that Black women were less upset about 
having to return for follow-up (sample mean = 3.1) compared to all women (sample mean 
= 3.4). The difference in staff members' ratings of distress in response to follow up 
approached, but did not reach statistical significance, t(23)=2.01, p=0.05. Site C did 
report significantly higher rates of distress for all women (3.9, p=0.04) and Black women 
(3.6, p=0.03) compared to the other sites. 
 Patient Characteristics. Demographic characteristics of the patient survey 
respondents are displayed in Table 2. Most of the respondents were in the 50-64 age 
range (53.9%), did not have a partner (67.5), had less than a college education (70.9%), 
and made less than $50,000 annually (75.2%). A third of respondents (29.9%) reported a 
family history of BRCA, and almost half (46.1%) had a FPM result during the study 
period. Respondents were well distributed across facilities when accounting for the 
demographics across screening sites. Patient satisfaction and provider communication 
scores are presented by site in Table 4. There were no statistically significant differences 
in scores by site. Mean satisfaction scores were in the middle of the range of possible 
scores for each subscale, while mean ratings of discrimination and disrespect during the 
clinical counter fell at the low range of scores. 
Influences on Satisfaction. Odds ratios demonstrating the influence of selected 
organizational, provider, and patient characteristics on different types of patient 
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satisfaction are depicted in Table 5. None of the factors tested influenced the odds that 
Black women would report high levels of general satisfaction. Respondents who recently 
experienced a FPM result were 66% less likely to be satisfied with the convenience and 
accessibility of mammography services. Women with recent FPM results were also 58% 
less likely to be satisfied with the way providers communicated these results to them. 
Reduced satisfaction with provider information given was also shared by women with 
family history of BRCA (64% less) and those experiencing discrimination (68% less) 
during their most recent mammography encounter. As with general satisfaction, provider 
interpersonal style was not influenced by any of the characteristics collected.  
Multiple factors were found to impact patient perceptions of providers’ technical 
expertise. Facility characteristics such as serving an older population, having more 
screening hours, and providers reporting a higher perception of patients' physical 
discomfort were associated with lower levels of satisfaction with providers' skills. 
Conversely, the presence of educational materials, higher perceptions of patient distress 
due to mammography, and being asked to complete mammography follow-up was 
associated with increased satisfaction with providers' expertise. Similar characteristics 
influenced women's satisfaction with the physical environment, with the presence of 
educational materials increasing satisfaction and higher screening hours and an older 
patient population linked to reduced satisfaction. 
Discussion 
The experience of receiving a FPM result may have an immediate and long lasting 
impact on Black women’s BRCA screening experiences, especially as it relates to their 
satisfaction with the clinical encounter. We examined multilevel influences on 
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mammography satisfaction among Black women receiving FPM results and generated 
mixed findings. First, we sought to determine if satisfaction levels differed by facility. 
Despite the varied characteristics of the mammography facilities assessed, no site-level 
differences in patient satisfaction were detected in this group of Black women. While it is 
possible that the sample size limited our ability to detect site-level differences, it is much 
more likely that standardization of patient notification and care procedures in this health 
system resulted in women having similar experiences across clinical sites.  
Next, we investigated the relationship between the various types of satisfaction and 
facility, provider, and patient characteristics. No influences on general satisfaction or 
satisfaction with provider interpersonal style were detected in this sample. Survey items 
in both subscales were very non-specific, (e.g. I was very satisfied with the care I 
received at the service; The staff had good manners.) thus there was no obvious 
connection between the domains and the factors tested. 
Multiple factors were found to be related to satisfaction with the convenience of 
mammography. As expected, FPM status was associated with low satisfaction with 
convenience, which is mostly likely a result of the challenges related to completing 
additional procedures.14,17 Surprisingly women with a family history of BRCA were also 
less likely to be satisfied with the convenience of mammography. The most probable 
explanation is that these women were asked to complete additional tests due to their 
increased BRCA risk, thus complicating their screening encounter. Experiencing 
discrimination also resulted in lower satisfaction with mammography convenience, 
paralleling findings linking mistrust to lower levels of mammography satisfaction in 
Black women.20 Evidence demonstrates that experiencing racial discrimination during 
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healthcare interactions is strongly associated with postponing/not accessing healthcare.30 
It is not unreasonable to conclude that Black women’s perceptions of convenience in 
accessing health services could be affected by perceived discrimination. 
Women’s satisfaction with providers’ ability to provide information during the 
screening process was negatively associated with FPM status. Multiple studies have 
reported that Black women are more likely to have inadequate or incomplete 
communication around abnormal mammography results.6,14,17,18,31 Communication needs 
for this group include: a preference for results delivered over the phone vs. the mail, 
definitions of terms used to explain results, and a more detailed description of the 
activities involved in mammography follow up.6,17,32 Actions to improve communication 
of mammography results should address cultural differences in communication in 
addition to implicit biases that may lead to perceptions of racial discrimination.33–35 
Similar factors appear to be related to perceptions of provider expertise as satisfaction 
with provider competence was positively associated with providers’ reporting higher 
levels of patient psychological distress and the presence of educational materials. Serving 
an older patient population, a higher number of weekly screening hours, and providers’ 
perception of a high level of physical discomfort on the part of patients was associated 
with lower levels of satisfaction with provider competence. Satisfaction with the clinical 
environment was influenced by the same facility features in the same directions. It is not 
exactly clear how these factors contribute to reduced satisfaction; one possibility is that 
both factors may lead to the perception of slower service in the waiting room and/or more 
hesitation on the part of the provider during the clinical encounter.   
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Our study has some limitations. Due to the small sample size, it was not possible to 
examine relevant characteristics for all three levels in one model. It is possible that some 
organization level effects may disappear in the presence of patient-level effects and vice 
versa. Additionally, certain patient-level factors that may influence satisfaction including 
patient health status and pain/discomfort felt during the clinical exam were not evaluated. 
Another point of consideration is the data for this study comes from multiple sites within 
a single hospital system. Examining satisfaction across multiple hospital systems might 
reveal additional influences on satisfaction due to the lack of standardization in 
procedures. Lastly, this study examined different categories of factors that affect patient 
satisfaction, but it did not link satisfaction to mammography follow-up times, follow up 
intention, or the completion of future follow-up procedures. Studies should be developed 
to allow for the examination of multilevel influences concurrently, that include additional 
influences on satisfaction at each level, span multiple health systems, and/or link 
satisfaction to mammography follow-up outcomes.  
Despite these limitations, we concluded that specific domains of Black women’s 
satisfaction with the mammography process are influenced by different categories of 
factors. Satisfaction with convenience and provider information transfer were largely 
impacted by individual experiences such as FPM status or family history, while 
satisfaction with provider competence and the facility environment were shaped by a 
combination of provider and facility-related factors. More attention needs to be paid to 
the aspects of the clinical encounter that shape Black women's experiences to determine 
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*Bolded values are statistical significant at the p<0.05 level 
 Site A Site B Site C Site D Site E 
 f %  f %  F % f % f % 
Screening Patient Demographics 
Age Range           
  40-49 1,951 17.9 1,155 21.8 734 19.9 247 18.1 513 29.4 
  50-64 4,699 43.2 2,455 46.3 1,548 42.0 605 44.3 942 54.0 
  65+ 4,234 38.9 1,690 31.9 1,408 38.2 513 37.6 291 16.6 
Race/Ethnicity           
  White 5,881 54.0 2,028 38.3 2,786 75.5 652 47.8 1,099 62.9 
  Black 4,620 42.5 3,050 57.6 733 19.9 621 45.5 523 30.0 
  Latina 133 1.2 64 1.2 23 0.6 15 1.1 14 0.8 
  Other 250 2.3 158 3.0 148 4.0 77 5.7 110 5.7 
Geographic Location           
  Rural 386 3.6 191 3.7 245 6.7 5 0.4 266 15.5 
  Urban 10,326 96.4 5,031 96.3 3,409 93.3 1,349 99.6 1,447 84.5 
Health Insurance Type           
  Private 5,368 49.3 2,561 48.4 1,981 53.7 689 51.4 1,283 73.5 
  Public 5,269 48.4 2,610 49.3 1,695 45.9 639 47.7 450 25.8 
  Uninsured 243 2.2 124 2.3 14 0.4 12 0.9 13 0.7 
Physical Characteristics 
# of Waiting Rooms 4  3  1  1  1  
# of Exam Rooms 15  14  4  1  3  
Educational materials? Y/N No  Yes  No  No  No  
Utilization Characteristics 
Procedures           
  Screening Visits 10,939 86.0 5,325 87.4 3,700 93.5 1,371 100.0 1,750 100.0 
  Diagnostic Visits 1,781 14.0 764 27.3 257 9.2 0 0 0 0 
Weekly 
Operating Hours 
          
  Screening 47.5  40  50  42  42  

























a Responses range from 1= No discomfort to 5 = A great deal of discomfort; b Responses range from 1= No distress to 5 = A great deal of distress;  
c Responses options: 1= Never, 2 = Seldom, 3 = About half the time, 4 = Usually, 5 = Always; *Bolded values are statistical significant at the p<0.05 level 
 
Characteristics Site A Site B Site C Site D 
f Mean (Std) f Mean (Std) f Mean 
(Std) 
f Mean (Std) 
How much physical discomfort do women 
experience during a mammogram?a 
 
10 2.7 (0.95) 12 2.4 (1.00) 8 3.0 (0.93) 2 3.5 (0.71) 
How much psychological distress do women 
experience during a mammogram?b 
 
10 2.4 (0.70) 12 2.5 (0.80) 8 2.5 (0.76) 2 2.0 (0.00) 
How often are women upset by this 
experience (getting called back for follow up 
testing)?c 
 
10 3.1 (0.88) 12 3.7 (0.89) 8 3.9 (0.35) 2 3.5 (0.71) 
How often are Black women upset by this 
experience (getting called back for follow up 
testing)?c 
 
10 3.0 (0.82) 12 3.33 (0.89) 8 3.6 (0.52) 2 3 (1.41) 
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 F % or 
Mean (Std) 
Race   
  Black/African American 117 100.0 
Age Range   
  40-49 22 18.8 
  50-64 63 53.9 
  65+ 32 27.3 
Marital Status   
  Married 35 29.9 
  Living with a partner 3 2.6 
  Widowed 22 18.8 
  Divorced 33 28.2 
  Separated 6 5.1 
  Single/Never Married 18 15.4 
Geographic Location   
  Urban 114 97.4 
Education   
  High school or less 83 70.9 
  College or more 34 29.1 
Income   
  Less than 50K 82 75.2 
  50K or more 27 24.8 
Health Insurance Type   
  Private 53 45.3 
  Public 60 51.3 
  Uninsured 4 3.4 
Family History of Breast Cancer - Yes 35 29.9 
% With False Positive Mammograms 54 46.1 
Screening Site   
  A 54 46.1 
  B 35 29.9 
  C 7 6.0 
  D 16 13.7 
  E 5 4.3 
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Table 4.5. Bivariable Logit Models Describing Associations with High Levels of Mammography Satisfaction Among Black Women*  











 OR (CI) OR (CI) OR (CI) OR (CI) OR (CI) OR (CI) 
Facility Factors       
Patient age: 50+ 0.72 (0.31-1.69) 0.62 (0.27-1.40) 0.63 (0.28-1.41) 0.57 (0.24-1.32) 0.35 (0.15-0.84) 0.39 (0.17-0.89) 
Patient age: 40-49 1.00 1.00 1.00 1.00 1.00 1.00 
Patient race:  
Majority Non-White 0.34 (0.06-1.80) 0.77 (0.20-2.92) 0.54 (0.13-2.13) 0.68 (0.15-2.98) 0.91 (0.21-3.82) 2.26 (0.60-8.48) 
Patient race:  
Majority White 1.00 1.00 1.00 1.00 1.00 1.00 
Patient insurance status:  
High % Non-Private 2.57 (0.51-12.70) 1.27 (0.35-4.55) 2.29 (0.61-8.58) 1.87 (0.46-7.57) 1.37 (0.37-4.99) 0.77 (0.22-2.70) 
Patient insurance status:  
Low % Non-Private 1.00 1.00 1.00 1.00 1.00 1.00 
# of Waiting rooms: High  0.78 (0.30-2.02) 1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31) 
# of Waiting rooms: Low 1.00 1.00 1.00 1.00 1.00 1.00 
# of Exam rooms: High 0.78 (0.30-2.02) 1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31) 
# of Exam rooms: Low 1.00 1.00 1.00 1.00 1.00 1.00 
# of Education materials: Present 1.02 (0.43-2.40) 1.56 (0.67-3.63) 1.49 (0.65-3.41) 1.89 (0.78-4.59) 3.04 (1.22-7.57) 2.95 (1.12-6.93) 
# of Education materials: Absent 1.00 1.00 1.00 1.00 1.00 1.00 
Patient volume: High 0.78 (0.30-2.02) 1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31) 
Patient volume: Low 1.00 1.00 1.00 1.00 1.00 1.00 
Screening hours:  High 0.87 (0.39-1.91) 0.86 (0.40-1.85) 0.71 (0.33-1.51) 0.64 (0.29-1.39) 0.45 (0.20-0.97) 0.38 (0.17-0.82) 
Screening hours: Low 1.00 1.00 1.00 1.00 1.00 1.00 
Diagnostic hours:  High 0.78 (0.30-2.02) 1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31) 
Diagnostic hours: Low 1.00 1.00 1.00 1.00 1.00 1.00 
Provider Factors       
Perception of patient discomfort: 
High 0.88 (0.37-2.08) N/A 0.64 (0.28-1.48) 0.53 (0.21-1.29) 0.32 (0.12-0.81) N/A 
Perception of patient discomfort: 
Low 1.00 1.00 1.00 1.00 1.00 1.00 
Perception of patient distress: 




*Bolded values are statistical significant at the p<0.05 level 
Perception of patient distress: 
Low 1.00 1.00 1.00 1.00 1.00 1.00 
Perception patient upset by 
follow up: High 1.07 (0.48-2.38) N/A 1.74 (0.80-3.79) 2.08 (0.93-4.66) 2.65 (1.19-5.92) N/A 
Perception patient upset by 
follow up: Low 1.00 1.00 1.00 1.00 1.00 1.00 
Perception Black patient upset 
by follow up: High 1.21 (0.53-2.77) N/A 1.94 (0.86-4.36) 2.40 (1.00-5.72) 1.94 (0.86-4.36) N/A 
Perception Black patient upset 
by follow up: Low 1.00 1.00 1.00 1.00 1.00 1.00 
Patient Factors       
FPM Results 0.73 (0.33-1.60) 0.34 (0.16-0.73) 0.42 (0.20-0.89) 0.62 (0.29-1.34) 0.58 (0.27-1.22) 0.52 (0.24-1.08) 
Normal Results 1.00 1.00 1.00 1.00 1.00 1.00 
Age Range       
  40-49 1.00 1.00 1.00 1.00 1.00 1.00 
  50-64 1.01(0.35-2.91) 1.12 (0.40-3.11) 0.96 (0.35-2.67) 0.88 (0.31-2.48) 0.39(0.13-1.17) 0.77 (0.28-2.12) 
  65+ 0.84 (0.26-2.072) 1.09 (0.72-5.31) 0.54 (0.17-1.69) 1.16 (0.36-1.83) 0.55 (0.16-2.60) 0.64 (0.21-1.98) 
Partnered  0.60 (0.26-1.35) 1.17 (0.52-2.64) 1.60 (0.71-3.60) 0.76 (0.34-1.72) 0.52 (0.23-1.17) 1.12 (0.51-2.47) 
Unpartnered 1.00 1.00 1.00 1.00 1.00 1.00 
High school or less 0.81 (0.33-1.96) 0.84 (0.36-1.96) 0.62 (0.26-1.45) 0.76 (0.32-1.82) 1.01 (0.44-2.32) 0.80 (0.35-1.82) 
College graduate or more 1.00 1.00 1.00 1.00 1.00 1.00 
Less than 50K 0.67 (0.25-1.78) 0.68 (0.27-1.72) 0.67 (0.27-1.64) 0.90 (0.36-2.28) 1.60 (0.66-3.88) 0.74 (0.30-1.81) 
More than 50K 1.00 1.00 1.00 1.00 1.00 1.00 
Private health insurance 0.91 (0.08-9.58) 0.88 (0.41-1.90) 0.61 (0.05-6.63) 0.56 (0.05-5.87) 0.48 (0.04-5.10) 0.46 (0.04-4.87) 
Public health insurance 1.00 1.00 1.00 1.00 1.00 1.00 
Family History of BRCA 0.58 (0.25-1.33) 0.35 (0.15-0.82) 0.72 (0.32-1.63) 0.51 (0.22-1.16) 0.67 (0.30-1.52) 0.51 (0.22-1.15) 
No Family History of BRCA 1.00 1.00 1.00 1.00 1.00 1.00 
High Discrimination Score 0.59 (0.23-1.51) 0.32 (0.12-0.87) 0.47 (0.18-1.22) 0.38 (0.15-0.96) 0.39 (0.15-1.00) 0.53 (0.20-1.36) 
Low Discrimination Score 1.00 1.00 1.00 1.00 1.00 1.00 
High Disrespectful Office Staff 
Score 0.56 (0.18-1.77) 0.99 (0.30-3.19) 0.57 (0.18-1.81) 0.47 (0.15-1.49) 0.82 (0.26-2.58) 0.46 (0.14-1.50) 
Low Disrespectful Office Staff 
Score 1.00 1.00 1.00 1.00 1.00 1.00 
 
1Farr DE, Brandt HM, Friedman DB, Armstead C, Adams SA, Fulton J, Bull D. To be 
submitted to American Journal of Preventive Medicine 
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4.2 False-Positive Mammography and Mammography Screening Intentions Among 






Abnormal mammograms confirmed as benign are known as false-positive 
mammography (FPM) results. Research indicates that a history of FPM results may be 
linked to mammography follow-up delays in Black women, yet much of the research on 
FPM has focused on White women. The purpose of this study was to examine the 
influence of FPM on breast cancer (BrCa) screening beliefs and intentions in Black 
women. BrCa-free, Black women, aged 40 and older who completed screening 
mammograms in 2016 were recruited for a case-control study. Print surveys assessing 
demographics, anxious personality, general anxiety, BrCa-specific anxiety, depression, 
BrCa screening history, BrCa beliefs, and Afrocentric coping behaviors were mailed to 
participants. Women with FPM results were cases, and women with normal results 
screened on the same day served as matched controls. The final sample consisted of 117 
respondents (54 cases, 63 controls). Ordinary least squares (OLS) models were 
constructed. Personality traits, emotional states, and coping behaviors were tested as 
mediators and moderators of the relationship between FPM results and BrCa beliefs. 
FPM status was associated with a higher perception of barriers to mammography and 
perceived barriers were associated with a lower intention to complete mammography. 
Afrocentric coping behaviors moderated the perception of mammography barriers for 
women with FPM results. FPM status had a detrimental impact on BrCa beliefs in Black 
women, but the use of collective coping behaviors weakened this relationship. Culturally 
specific research focused on Black women is needed to explore influences on BrCa 






Despite a continuous decrease in breast cancer (BrCa) mortality among American 
women, racial inequities in BrCa mortality have remained constant.1 An important driver 
of these inequities among Black women is their increased rate of advanced staged tumors 
at diagnosis, which is partially due to delays in mammography screening resolution.2–6 
Delayed mammography follow-up in Black women has been attributed to various social, 
cultural, and socioeconomic factors, but the influence of Black women’s prior healthcare 
experiences, such as receiving a false-positive mammography (FPM) result has not been 
fully explored.7–9  
FPM results are abnormal screening mammograms that are determined to be non-
malignant after diagnostic testing.10–12 Clinically, FPM results correspond to a Breast 
Imaging Reporting and Data System (B-IRADS) classification of 0 (Incomplete - 
additional imaging evaluation and/or comparison to prior mammograms in needed), 3 
(Probably benign finding), 4 (Suspicious abnormality) or 5 (Highly suggestive of 
malignancy).13 Normal mammograms are classified as BI-RADS 1 or 2.13 Anywhere 
from 5-10% of mammograms each year result in a FPM, but cumulatively, a woman has 
a 41.6-61.3% chance of receiving a FPM result during her screening life depending on 
the age at which she initiates screening (anytime between 40 and 50 years of age) and her 
screening schedule (annual vs. biennial).10,14–17 FPM may lead to potentially negative 
outcomes, such as additional financial costs due to follow-up testing, impaired daily 





Recent systematic reviews report that despite experiencing general and BrCa 
specific anxiety after receiving a FPM, American women are more likely to complete 
screening mammograms than their European and Canadian counterparts.10,18 Very few 
studies of FPM assess BrCa screening beliefs or integrate health behavior theory, so the 
exact mechanism that links FPM results with increased mammography completion is 
unknown. Furthermore, these findings may not apply to Black women as they have not be 
included in sufficient numbers or a part of subgroup analyses in studies of this 
topic.10,16,17,19–23  
A handful of studies have examined FPM outcomes in women of color, but these 
studies mainly compared the emotional states of White women to heterogenous groups of 
women of color.24,25 As a result, these studies have produced inconsistent findings 
regarding the effects of FPM results non-White women.24,25 The only study to compare 
Black women with FPM to those with normal results found that FPM status was 
associated with higher levels of worthlessness and restlessness.26  
Black women’s experiences with and reactions to FPM may be an important 
aspect of their screening experience. One qualitative study of Black BrCa survivors 
presented accounts of women who delayed seeking care for lumps due to past FPM.27 In 
another study by Kerner et al., Black women who completed mammography follow-up 
after the 90-day window were more likely to have had an abnormal mammogram in the 
past and displayed higher levels of anxiety than Black women with normal results.28 
Together these findings imply a potential link between prior FPM and mammography 




Racial differences are not limited to influences on screening behaviors, but also 
extend to the impact of coping strategies. In general, coping behaviors vary across 
racial/ethnic groups and in response to different events, necessitating the use of culturally 
specific assessments to adequately describe these behaviors.29,30 A study of FPM results 
and coping behaviors found that Latinas engaged in more avoidant and religious coping 
which led to higher levels of distress than their White counterparts.31 Racial variation in 
screening and coping outcomes of FPM results underscores the need for studies that 
focus on Black women to develop contextually relevant theories and knowledge about 
screening influences in this population.32 
The goal of this study was to examine the influence of FPM results on 
mammography beliefs among Black women. Components of the transactional model of 
stress and coping and the health belief model guided the data collection and analysis for 
this study.33,34 A FPM result can be conceptualized as a stressful event which leads to 
concurrent primary and secondary appraisals.33 Primary appraisals generate emotional 
responses, while secondary appraisals lead to a course of action which may include 
coping responses.33,35 BrCa screening beliefs, specifically influential predictors of 
mammography behaviors such as the Health Belief Models’ perceived benefits and 
perceived barriers constructs, can be influenced by women’s coping responses.33,35,36 
Personality traits, cultural differences in social contexts, and emotional expression can 
also impact appraisal and the relationship between health beliefs and behaviors.35–37 The 
variability of these characteristics across racial/ethnic groups may generate different FPM 




We (the authors) hypothesized that FPM results will adversely effect BrCa 
screening beliefs. As part of the appraisal process, emotions will mediate the relationship 
between BrCa beliefs and FPM status. Personality traits and coping behaviors will 
moderate these relationships. FPM status will have detrimental effects on mammography 
intention as will high levels of perceived susceptibility to BrCa, high levels of perceived 
mammography barriers, and low levels of perceived mammography benefits.  
Methods 
Setting. This study was conducted in collaboration with a leading provider of 
mammography services in Richland County, South Carolina.2 Richland County is an area 
where 46% of the population was classified as African American/Black.38 Study activities 
were approved by the Palmetto Health Institutional Review Board. 
Study design. Preliminary estimates indicated FPM results represented 6% of 
screening mammograms performed at the participating health system during any 12-
month period. A case-control study design was implemented given the rarity of FPM 
results in a single year. Eligible participants were selected from records of women 
completing screening mammograms at eligible facilities between January and August 
2016. Black women aged 40 and older, BrCa free for five years or more, no indication of 
major mental illness, and whose final mammography results were confirmed as benign 
were eligible to participate. Women whose screening mammograms were classified as 
BI-RADS Category 0 were selected as cases.13 One control participant was selected from 
eligible women who completed screening on the same day and at the same facility, but 
had normal results (BI-RADS Category 1 or 2).13 Packets containing surveys, postage 




participants five to six months after their initial screening mammograms to allow for 
screening resolution (June 2016-January 2017). Reminder letters were sent to non-
responders one month after the initial mailing and prior to the end of the study. Medical 
records were used to confirm BrCa screening history information reported via survey. 
Measures. Patient age, zip code, health insurance information, and screening 
facility were obtained from patient medical records. Patient zip codes were matched to 
counties, and the National Center for Health Statistics Urban-Rural Classification 
Scheme for counties was used to classify areas as urban or rural.39 The South Carolina 
Department of Health and Human Services website and the National Committee for 
Quality Assurance Health Insurance Plan Ratings 2016-2017 were used to identify 
insurance products, which were further collapsed into three categories: private, public, 
and uninsured.40,41 Survey questions assessing patient education, family history of 
BRCA, and age at first mammogram were modeled after items on the National Health 
Interview Survey.42 
BrCa beliefs were measured using the Champion Attitudes Towards 
Mammography and Breast Cancer Scale, an assessment of the health belief model which 
was developed using Black women.43 The Perceived Benefits, Perceived Susceptibility, 
and a shortened 10-item version of the Perceived Barriers subscale were included in this 
study.43 All three subscales displayed high internal consistency in this sample with α= 
0.70, 0.84, and 0.85, respectively. Intention to complete future screening mammograms 
and follow-up tests were each assessed with a single item: 1) How likely are you get your 
next screening mammogram as scheduled? and 2) If you asked to return for follow-up 




additional tests? Response categories were 1=Very Unlikely, 2=Unlikely, 3=Likely, and 
4=Very Likely. 
Anxious personality and general anxiety were measured using the 10-item short 
forms of the Spielberger State-Trait Anxiety Inventory (STAI) Trait and State Anxiety 
Scales.44 A six-item anxiety subscale of the Psychological Consequences Questionnaire 
DK-33 (PCQ-DK33) was used to assess BrCa-specific anxiety and displayed high 
reliability in this population (α= 0.93).45 Depression was assessed with the Center for 
Epidemiologic Studies Depression Scale Short Form (CES-D 10).46,47 
The Africultural Coping Systems Inventory (ACSI) measures coping behaviors 
used by Black Americans and contains four subscales: cognitive/emotional debriefing, 
collective, spiritual-centered, and ritual centered.48 Reliability coefficients for the four 
ACSI subscales in the current sample ranged 0.78 to 0.89.  
Statistical analysis. Analyses were conducted in STATA 13.49 Chi-square tests 
were employed to examine demographic differences between case and control 
participants. T-tests and ANOVA were used to examine differences in BrCa beliefs and 
psychosocial factors. Study hypotheses were tested using OLS models. Variables with 
theoretical relationships to the outcome of interest were included in the models. Missing 
observations were removed from models via case-wise deletion. The ‘khb command’ in 
STATA (Sobel test) was used to test for mediation. Continuous variables were centered 
at the mean value for the overall sample. Separate models with interaction terms 
combining the main independent variable (FPM status) with anxious personality, anxiety, 




characteristics on the main outcome variables (BrCa beliefs). An alpha of 0.05 was used 
to determine statistical significance in all models. 
Results 
Between January and August 2016, 9,826 Black women completed screening 
mammograms and were eligible for study participation. In total, 909 survey packets were 
mailed (411 cases, 498 controls), 25 surveys were returned to sender, and two recipients 
reported ineligibility and did not return surveys. Of the remaining 882 surveys 
distributed, 133 (15.0%) were returned. Five survey participants were found to be 
ineligible due to recent BrCa diagnoses or mental illness. Another 11 were excluded from 
analyses due to missing information or conflicting responses. The final analytic sample 
consists of 54 case and 63 control participants for a total of 117 respondents. Most of the 
survey respondents were aged 50 and older, had at least a high school education, and had 
health insurance coverage. Table 1 displays demographic, BrCa screening, and 
psychosocial information for both groups. Case and control respondents were similar on 
demographic variables, but significant differences were detected in the mammography 
barriers scores. Women with FPM results reported an increased perception of barriers 
compared to women with normal results (13.8 vs. 12.2, p=0.04). Additionally, women 
with FPM results displayed more general and BrCa-specific anxiety compared to women 
without FPM results. Both groups of women reported using similar coping styles, except 
for cognitive/emotional coping behaviors which were more prevalent among women with 
FPM results. 
Multiple OLS models were constructed to investigate the influence of FPM 




susceptibility to BrCa (R2 =0.22, p=0.00) and the perceived barriers to mammography 
(R2=0.19, p=0.00) were statistically significant. Receipt of FPM results was associated 
with a higher perceived barriers score. Anxious personality, anxiety, depression, and 
coping strategies were tested as mediators, but none of these variables explained this 
relationship. Testing for effect moderation revealed that the use of collective coping 
behaviors was associated with a lower mean perceived barriers score among women with 
FPM results (Figure 1.) 
Separate models describing the screening and follow-up testing intentions were 
constructed (Table 3.) Perceived benefits of mammography were not included in BrCa 
screening and diagnostic intention models being that the base model was not statistically 
significant. Neither type of intention was influenced by perceived BrCa susceptibility 
(R2=0.09, p=0.53; R2=0.10, p=0.40 for screening and follow up intention respectively). 
Both intentions to complete screening mammography (R2=0.21, p=0.00) and diagnostic 
testing (R2=0.31, p=0.00) were inversely associated with the perceived barriers score. 
Discussion 
Previously unasked questions about the relationship between FPM, BrCa 
screening beliefs, and mammography intentions in a sample of Black women were 
explored in this study. We hypothesized that FPM status would lead to lower levels of 
perceived mammography benefits, higher levels of perceived susceptibility to BrCa, and 
perceived barriers to mammography. In our sample, FPM status was not associated with 
the perception of the benefits of mammography nor perceived susceptibility to BrCa. 
Previous studies consistently reported elevated mammography benefits and BrCa 




benefits has not been shown to impact mammography adherence, regardless of race, 
BrCa susceptibility has been linked to increased motivation to complete mammography 
among White women.10 Research on perceived susceptibility to BrCa suggests that Black 
women perceive lower levels of BrCa risk and that perceived susceptibility has no 
influence on their BrCa screening behavior.37,50 Our findings regarding perceived 
susceptibility corresponds with the literature describing BrCa screening beliefs among 
Black women in general. 
In our study, FPM status was associated with an increased perception of barriers 
to mammography, which conflict with DeFrank et al.’s findings of no relationship 
between these factors.16 This difference is likely due to the fact that we used the 
Champion barrier items which assessed logistical, psychosocial, and financial concerns, 
while DeFrank et al. only examined financial barriers to mammography completion.16,43 
It is not surprising that women with FPM status reported more barriers given their 
experience with the various challenges associated with the completion of follow up 
testing. 
We also hypothesized that anxiety and depression would mediate the relationship 
between BrCa beliefs and FPM status, and personality traits and coping behaviors would 
function as moderators of this relationship. We did not uncover any mediators, but the 
employment of collective coping strategies were found to decrease the perception of 
mammography barriers.  
Collective coping as measured by the ACSI is similar to the social support 
subscales of other assessments such as the Brief COPE, but the ACSI subscale contains 




experience.30,48,51 The positive effect of this coping style appears to indicate that 
collective coping strategies are protective for individuals in more collective cultures. 
Molina et al. found differences in coping behaviors and negative psychosocial outcomes 
between White and Latina women, but the impact of collective coping strategies on 
psychosocial outcomes was not reported due to inadequate reliability of the Brief COPE’s 
social support subscale.31 Another analysis conducted by the same authors revealed 
negative psychosocial outcomes among Latina women with FPM results who did not 
discuss their results with their family or friends.52 Together, these findings demonstrate 
the need for investigations of the effect coping behaviors on BrCa screening outcomes 
among women of color with FPM results.  
Lastly, we postulated that the impact of FPM status on BrCa behavioral beliefs 
would lead to lower mammography intention among the women surveyed. This 
hypothesis was only supported for the perception of barriers to mammography. In this 
sample, high levels of perceived mammography barriers were associated with the receipt 
of FPM results and decreased intentions to complete mammography screening and 
follow-up testing. In DeFrank et al.'s study, FPM status was connected with the delayed 
completion (longer than two years) of participants' next screening mammography, and 
mammography delay was mediated by provider recommendation.16 Women with FPM 
results were more likely to experience mammography delays if they did not receive a 
mammography recommendation.16  
It will be important to examine whether provider recommendation has similar 
impact on subsequent mammography behavior among Black women with FPM results, 




recommendations with their Black patients.53,54 In this sample, respondents were asked 
the reason for their most recent screening mammogram using a multi-select survey item. 
Twenty-six percent of respondents indicated scheduling their index mammogram due to a 
recommendation from their provider (there were no differences in cases and controls). 
Most respondents (82.7%) reported scheduling screening mammograms “because it was 
time”. This finding appears to confirm the lack of provider discussion about 
mammography reported in other studies.53,54 
Limitations. The following limitations should be noted when considering the 
study’s findings. Psychosocial measures were collected retrospectively, thus were subject 
to recall bias. As both groups were subject to recall bias, we believe the impact on our 
findings is minimal. It is possible that there were small differences in BrCa screening 
beliefs that could not be detected due to the relatively small sample size. This study 
examined BrCa screening and follow-up intentions, not actual behavior. Cross-sectional 
sampling used for analysis makes this study exploratory, but provided information that 
can guide longitudinal studies of FPM outcomes among Black women.55 
Additionally, the long-term effect of receiving an FPM result are unclear as 
respondents were assessed between 6 and 12 months after their index mammogram 
(mean response time was 199 days). Respondents were asked if they had a FPM before 
their most recent mammogram and 24% of controls reported a previous FPM result. 
Sensitivity analyses were run with respondents who ever had a FPM serving as cases and 
those never receiving a FPM result as controls. Similar trends emerged from this analysis, 
but many did not achieve statistical significance. These results suggested that effects of a 




specifically the use of: a case-control design, culturally appropriate standardized 
measures, clinical records to validate FPM status, and a theoretically grounded 
conceptual model to guide measure selection and data analysis.   
Conclusions 
Influences on BRCA screening beliefs and mammography intentions vary as 
result of the different social and cultural contexts that shape their healthcare experiences. 
Black women exist in an environment with lower levels of BrCa knowledge, fewer 
discussions with healthcare providers about BrCa screening, and high rates of BrCa 
mortality, thus the use of collective coping strategies improves Black women’s response 
to the potentially negative experience of receiving FPM results.1,8 Our findings highlight 
the importance of conducting culturally specific research with groups that experience 
racial inequalities, as behavioral pathways and solutions may vary by racial/ethnic group. 
Additional research examining the influence of Black women’s previous BrCa screening 
encounters and responses to those encounters is needed to better understand behavioral 
factors linked to mammography delay. 
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Table 4.6 Demographic, Screening, and Psychosocial Characteristics of Black 
Women Completing Screening Mammography by Outcome n =117* 
 Cases  










Percentage (%) or 
Mean (Std) 
Age Range     
  40-49 14 25.9   8 12.7 
  50-64 25 46.3 38 60.3 
  65+ 15 27.8 17 27.0 
Education     
  High school or less 34 63.0 49 77.8 
  College or more 20 37.0 14 22.2 
Health Insurance Type     
  Private 26 48.2 27 42.9 
  Public 27 50.0 33 52.4 
  Uninsured   1   1.8   3   4.7 
Geographic Location     
  Urban 52 96.3 62 98.4 
Family History of Breast Cancer - 
Yes 
16 29.7 19 30.2 
Age at First Mammogram     
  Less than 30 years old   7 13.5   7 11.5 
  30-39 years old 26 50.0 23 37.7 
  40-49 years old 15 28.9 25 41.0 
  50 years or older   4   7.6   6   9.8 
Perceived Susceptibility  
(Range: 4-15) 
43   7.2 (2.7) 55   7.3 (2.7) 
Perceived Benefits (Range: 10-16) 52 14.5 (1.8) 61 14.4 (1.8) 
Perceived Barriers (Range: 10-26) 50 13.8 (4.7) 57 12.2 (3.2) 
Intention – Screening 
Mammography 
    
  Very Likely 50 92.6 59 93.7 
  Likely   3   5.6   3   4.8 
  Unlikely   1   1.8   0   0.0 
  Very Unlikely   0   0.0   1   1.5 
Intention – Mammography Follow 
Up 
    
  Very Likely 49 90.7 57 91.9 
  Likely   4   7.4   4   6.5 
  Unlikely   0   0.0   0   0.0 
  Very Unlikely   1   1.9   1   1.6 
Trait Anxiety (Range: 10-32) 46 17.4 (5.1) 52 17.2 (5.3) 
State Anxiety (Range: 10-34) 49 19.4 (4.9) 56 16.4 (4.8) 
Breast Cancer Specific Anxiety  
(Range: 0-18) 
53   4.3 (4.7) 57   2.2 (3.5) 
Depression (Range: 0-22) 44   6.0 (5.8) 56   3.9 (4.9) 
Coping Style     
  Cognitive/Emotional (Range: 0-31) 45 13.0 (8.9) 54   9.3 (8.8) 
  Collective (Range: 0-21) 50   6.0 (5.2) 54   6.1 (5.9) 
  Spiritual (Range: 0-27) 46 14.2 (7.6) 54 12.5 (8.2) 
  Ritual (Range: 0-9) 53   0.7 (1.5) 57   0.9 (1.9) 




Table 4.7 Multiple Regression Models Describing Influences on Breast Cancer 
Screening Beliefs*  
 Perceived 
Susceptibility 
Perceived Benefits Perceived 
Barriers 
Model R2 0.22 0.09 0.21 
Independent Variables    
 Mean (SE) Mean (SE) Mean (SE) 
Case  
(FPM Result) 
6.5 (0.6) 14.8 (0.4) 13.4 (0.9) 
Control 6.8 (0.6) 14.5 (0.4) 11.4 (0.9) 
Age Range    
  40-49 5.6 (0.8) 14.4 (0.5) 11.6 (1.1) 
  50-64 7.0 (0.6) 14.8 (0.4) 13.1 (0.8) 
  65+ 7.4 (0.8) 14.7 (0.5) 12.5 (1.1) 
Education:      
High school or 
less 
6.4 (0.6) 14.5 (0.4) 13.2 (0.9) 
College or more 6.9 (0.6) 14.8 (0.5) 11.6 (1.0) 
Health Insurance:    
  Private 7.8 (0.4) 14.3 (0.3) 10.5 (0.7) 
  Public 7.1 (0.4) 14.4 (0.3) 11.8 (0.8) 
  Uninsured 5.0 (1.5) 15.2 (1.1) 14.9 (2.0) 
Family History of Breast Cancer    
  Yes 7.2 (0.7) 14.5 (0.5)  
  No 6.1 (0.6) 14.8 (0.4)  
Breast Cancer Specific Anxiety 
(Centered at Mean) 
6.6 (0.6) 14.6 (0.4)  
Age at First Mammogram:    
  < 30 years old   10.9 (1.2) 
  > 30 years old   13.9 (0.8) 






Table 4.8 Multiple Regression Models Describing Influences on Breast Cancer Screening Intentions 
 Mammography Screening 
Intentiona 
Mammography FollowUp  
Intentiona 
Model R2 0.09 0.21 0.10 0.31 
Independent Variables     
 Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
Case  
(FPM Result) 
3.8 (0.1) 3.8 (0.1) 3.7 (0.1) 3.8 (0.1) 
Control 3.9 (0.1) 3.8 (0.1) 3.9 (0.1) 3.8 (0.1) 
Age Range     
  40-49 3.8 (0.1) 3.8 (0.1) 3.9 (0.1) 3.8 (0.1) 
  50-64 3.8 (0.1) 3.8 (0.1) 3.9 (0.1) 3.8 (0.0) 
  65+ 3.8 (0.1) 3.8 (0.1) 3.7 (0.1) 3.8 (0.1) 
Education:       
High school or 
less 
3.8 (0.1) 3.8 (0.1) 3.8 (0.1) 3.8 (0.1) 
College or more 3.9 (0.1) 3.8 (0.1) 3.8 (0.1) 3.8 (0.1) 
Health Insurance:     
  Private 4.0 (0.1) 4.0 (0.1) 3.9 (0.1) 4.0 (0.0) 
  Public 3.9 (0.1) 3.9 (0.1) 3.9 (0.1) 4.0 (0.0) 
  Uninsured 3.6 (0.2) 3.6 (0.1) 3.6 (0.2) 3.6 (0.1) 
Family History of Breast Cancer     
  Yes 3.8 (0.1)  3.8 (0.1)  
  No 3.8 (0.1)  3.8 (0.1)  
Breast Cancer Specific Anxiety (Centered at Mean) 3.8 (0.1)  3.8 (0.1)  
Age at First Mammogram:     
  Less than 30 years old  3.8 (0.1)  3.8 (0.0) 
  More than 30 years old  3.8 (0.1)  4.0 (0.0) 
Perceived Susceptibility (Centered at Mean) 3.8 (0.1)  3.8 (0.1)  
Perceived Barriers (Centered at Mean)  3.8 (0.0)  3.8 (0.0) 




Figure 4.1. Black Women’s’ Perception of Mammography Barriers by Screening Results 











































CHAPTER 5.  
SUMMARY, IMPLICATIONS, AND RECOMMENDATIONS 
 This chapter contains an integrated summary of the results presented in Chapter 4. 
A discussion of the results, study limitations, conclusions, and implications for public 
health practice and cancer inequities research is presented. Future research directions 
generated from this work will also be presented. 
5.1 Summary of Findings 
This purpose of this dissertation research was to determine the impact of 
multilevel factors on the processes and outcomes associated with FPM results in Black 
women. The study had two specific aims. 
Specific Aim 1: To describe, using a mixed methods approach, the organizational 
and provider-level characteristics of mammography facilities and their impact on Black 
women’s FPM experiences and outcomes. 
Research Question 1.1. What organizational, provider, and patient-level 
characteristics predict high levels of satisfaction with their clinical encounter among 
Black women experiencing a FPM result? 
Of the six domains of satisfaction examined, general satisfaction and satisfaction 
with provider’s interpersonal style were not influenced by any of the characteristics 
included in this analysis. Satisfaction with the convenience of mammography was 
inversely related to patient factors, such as having a FPM result, experiencing 
discrimination during the screening encounter, and having a family history of BrCa. The 
 
108 
negative influence of FPM status and experiencing discrimination on satisfaction with 
convenience mirror the findings of previous studies of this relationship.158,178,194,222,263 
Meanwhile, less data were available to describe the relationship between family history 
and satisfaction with mammography convenience.  
Even though FPM rates were higher among women with a family history of 
BrCa45, the proportion of women in this sample who had ever had a FPM result was not 
significantly different for women with and without a family history of BrCa (62.8% vs 
57.3%, p = 0.68). It is possible that some other aspect of the screening experience, 
potentially additional testing not related to abnormal mammography results, may impact 
satisfaction for this subgroup of Black women. Yet, it is not entirely clear what 
mechanism is responsible for the decreased satisfaction among this subpopulation of 
Black women as so few studies of family history have included Black women or 
mentioned the race of study participants.282–284  
Satisfaction with provider’s communication of information was solely influenced 
by FPM status. Women with FPM results were less likely to be satisfied with the 
information they received during their clinical encounters. Inadequate communication 
concerning abnormal screening results has been a recurrent theme in studies of BrCa 
screening follow-up in Black women.89,154,194,263,269 
Both satisfaction with provider competence and the physical environment were 
associated with facility and provider-related characteristics. In particular, the presence of 
educational materials increased women’s satisfaction with provider’s expertise and the 
clinical environment. Previous work on satisfaction with the mammography process, in 
general, has looked only at a few aspects of the facility environment not related to 
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communication, such as waiting times or ease of scheduling. 158,178,260 We found that 
higher levels of dissatisfaction were associated with an older patient population, more 
screening hours, and increased levels of providers’ concern with patients’ physical 
discomfort. It is possible that the age of the patient population and a greater number of 
screening hours may increase women’s perception of longer waiting times. Providers’ 
concern about physical discomfort may have served to make them timid and/or less 
confident with patients during the clinical encounter. 
Specific Aim 2: To determine, through quantitative methods, the relationship 
between receiving a FPM result and future mammography intention among Black 
women. 
Research Question 2.1. What is the relationship between receiving a FPM result 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) among Black women? 
Of the three BrCa screening beliefs measured, FPM only had a direct influence on 
the perception of barriers to mammography screening. The lack of relationship between 
perceived BrCa susceptibility and FPM status fits with several previous analyses of these 
variables.43,151,163,168 Other studies examining the connection between the perceived 
benefits of mammography and FPM status also failed to find a significant 
association.177,178  
Another explanation for null results as it relates to the relationships between FPM 
status, perceived susceptibility to BrCa, and benefits of mammography may be the timing 
of the assessment. Given that women were asked to recall their state of mind for an event 
which occurred 6 months prior, it is possible that women’s memories are influenced by 
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their final results. It is equally likely that topics such as barriers to screening may be more 
salient and easier to recall compared to concepts such as susceptibility to BrCa or the 
benefits of screening. 
Women with recent FPM results displayed a higher perception of screening 
barriers. These results are in direct contrast to DeFrank et al. (2012) who reported no 
association between FPM status and perceived barriers score.43 Differences in these 
findings may be attributed to differences in measurement of perceived barriers. DeFrank 
et al. (2012) used unstandardized items that only assessed financial barriers as opposed to 
the current study which assessed financial, logistical, and psychosocial barriers using a 
shortened version of the barrier subscale of the Champion Attitudes Towards 
Mammography and Breast Cancer Scale.43,258 It is likely that the barriers assessed by the 
Champion Attitudes Towards Mammography and Breast Cancer Scale are more 
representative of the varied outcomes associated with the receipt of FPM and allowing 
for the detection of the relationship between these two variables.37,38,258 
Research Question 2.1.a. Do Black women’s emotional states explain the 
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of 
mammography, perceived BrCa susceptibility, and perceived barriers to mammography 
screening)? 
Levels of general anxiety, BrCa-specific anxiety, and depression were assessed 
and tested as mediators of the relationship between perceived barriers and FPM status. 
Trait anxiety appeared to function as mediator in preliminary tests; thus it was included in 
mediation analyses. None of these factors explained the relationship between this BrCa 
screening belief and mammography outcome. The transactional model of stress and 
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coping conceptualizes that individuals will generate multiple appraisals in response to 
stressful events.200,201 Primary appraisals lead to emotional responses while secondary 
appraisals lead to coping behaviors and/or changes in beliefs. Emotions are theorized to 
accompany appraisals and not influence appraisals. The independent nature of the 
primary and secondary appraisals and different states affected would explain the lack of 
relationship between emotional states and BrCa screening beliefs.201 
Research Question 2.1.b. Does the relationship between receipt of FPM results 
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa 
susceptibility, and perceived barriers to mammography screening) vary by coping 
strategy employed? 
Several coping styles were tested to determine if they had any influence on the 
relationship between perceived barriers to mammography and FPM status. Of the 
different coping styles measured (cognitive/emotion debriefing, collective, spiritual-
centered, and ritual-centered), collective coping was found to decrease the detrimental 
influence of FPM results on the perception of barriers to mammography. Black American 
culture is highly collective due to its origins in African culture and the need to engage in 
collective behavior to survive various forms of racial oppression and disenfrachisement. 
These findings along with other studies illustrate how the collective aspects of Black 
culture can serve as resources that Black women can access to improve their 
health.63,237,238 Previous research on coping behaviors in response to a FPM result 
examined the relationship between coping behaviors and emotional states/distress, as 
opposed to BrCa beliefs.157,180 In the current sample, none of the coping strategies 
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measured were found to alter the relationship between FPM status and anxiety (general 
nor BrCa-specific).  
Research Question 2.2. What is the relationship between BrCa behavioral beliefs 
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived 
barriers to mammography screening) and intention to complete future mammography 
screening? 
 To establish the potential link between FPM and mammography intention in this 
small sample, models linking BrCa screening beliefs and mammography intention were 
created. Mammography intention was found only to be influenced by the perception of 
barriers to mammography. It is not surprising that the perceived benefits of 
mammography and the perceived BrCa susceptibility were not related to mammography 
intention in this sample. Reviews of the health belief model constructs failed to find a 
relationship between perceived benefits and mammography screening behavior.189,285 
Despite evidence that perceived susceptibility increases mammography screening 
behavior among White women, this relationship has not been detected among samples of 
Black women.189,190,274 Perceived barriers to mammography has been consistently 
associated with lower levels of mammography intention and screening, and the current 
study replicates these findings.189,285 
 In summary, multilevel factors were proven to influence the BrCa screening 
experiences of Black women with FPM. Organizational and provider level characteristics 
had positive and negative effects on Black women’s satisfaction with BrCa screening 
services in general. FPM status was related to lower levels of satisfaction and increased 
perceptions of the barriers to completing BrCa screening services. Literature indicates 
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that mammography satisfaction facilitates and the perception of barriers to 
mammography inhibit mammography behaviors.189,260–262,285 The findings of this 
dissertation research point to a link between FPM status and mammography behaviors 
through perceptions of the screening experience and subsequent influences on BrCa 
screening beliefs. 
5.2 Strengths and Limitations 
Conclusions drawn from the research findings are strengthened by several 
features of the study. This research includes a dedicated examination of influences in 
mammography satisfaction among Black women which is an important, but understudied 
topic. As a result, valuable information about the characteristics of the clinical encounter 
related to satisfaction for Black women may be used to guide future work on this topic. 
Additionally, the use of mixed-methods to collect information about features of the 
physical and social environment of healthcare facilities represents a more comprehensive 
approach to describing how the clinical environment influences patient experiences 
compared to quantitative-only or qualitative-only studies. Another asset of this research 
relates to the designs employed to address both specific aims. Linking characteristics at 
the organization, provider, and patient levels to women’s experiences at a single 
screening episode is a novel feature of this work as many studies of mammography 
screening only examine influences at one or two levels at most. Applying a case-control 
design to the investigation of the relationship between FPM status and BrCa screening 
beliefs and intentions enhances the internal validity of the results as does the use of 
culturally appropriate measures of BrCa screening beliefs and coping behaviors. The use 
of clinical measures to validate self-reported screening data also strengthens our 
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conclusions. Lastly, the use of a theoretically and empirically grounded conceptual model 
enhanced the selection of appropriate variables and analytic methods to understand how 
FPM results affect Black women. 
There were several limitations of this work that may impact the interpretation of 
the results. First is the small sample size. This issue prevented the inclusion of 
organizational, provider, and patient-level factors in one model for each type of 
mammography satisfaction. Another challenge associated with small sample size was the 
inability to collect data from all healthcare providers with patient contact. These 
limitations make the analyses of influences on mammography satisfaction, BrCa 
screening beliefs, and mammography intention exploratory in nature. However, these 
analyses can support the identification of variables to be incorporated in future studies of 
mammography beliefs and behaviors. 
Secondly, data for this study came from a single health system reducing the 
external validity of the results. Time and financial constraints would not allow for the 
inclusion of multiple hospital systems to generate a representative sample. A feature of 
this study linked to the focus on a single hospital system is the opportunity to examine the 
impact of standardized notification procedures on mammography satisfaction. This 
characteristic of the system limited our ability to determine how specific communication 
methods/protocols may impact satisfaction. Yet, the focus on a single system also proved 
to be a strength of the study as it allowed for the explanation of the lack of site-level 
differences in mammography satisfaction despite the variation in all of the other 
characteristics of the participating sites.  
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Third, the provider and patient surveys did not measure all variables that may 
influence women’s FPM experiences. In the case of the provider survey, factors, such as 
the volume of images read or the double reading of images, were not assessed. These 
factors are only relevant for radiologists, which represent 12.5% of the provider survey 
respondents. Few studies examined how non-physician staff involved in mammography 
procedures impacted women’s clinical encounters and this study provided important 
information as to how non-physician staff shaped women’s experiences.  
Medical conditions/issues, such as pain during the mammography procedure, 
mental health diagnoses, and chronic conditions that limit mobility or ability to complete 
mammography screening and follow-up procedures, were not assessed as part of the 
patient survey. Other cancer-related beliefs such as fatalism and medical mistrust have 
been shown to be salient influences in this population, but they were not included in the 
patient survey. These factors may impact women’s experiences and intention to complete 
screening; however there is no reason to believe that these factors would vary 
considerably between cases and controls. Psychosocial outcomes, including worry, fear, 
and distress, were associated with FPM status in other studies, but these variables were 
not measured in this study to minimize respondent burden.  
Fourth, the primary endpoint of the analyses examining individual FPM outcomes 
was mammography intention and not behavior (i.e. repeat mammography). Studies are 
inconsistent as to the links between mammography intention and actual mammography 
behaviors.189,285 Given that recommended mammography screening intervals range from 
one to two years; it was not feasible to collect prospective screening data for this study. 
The assessment of perceived barriers to mammography, the BrCa screening belief most 
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consistently associated with mammography behavior, did strengthen the assertion of a 
link between FPM status and future mammography behavior. 
Lastly, the fact that patient survey respondents were asked to retrospectively 
recall emotions and mammography experiences has to potential to weaken the study 
findings. Participants were surveyed six months after the initial screening mammogram to 
allow for the verification of final screening results. On average, diagnostic results were 
verified in this sample within three months, and future studies should consider a shorter 
follow-up time to reduce the potential for recall bias. Yet, the case-control design of this 
study was designed to yield two groups that were similarly affected by recall bias as well 
as social desirability to indicate intentions to complete future BrCa screening. 
5.3 Conclusions 
The goal of this study was to examine how multilevel factors, characteristics of 
the organizations, healthcare providers, and patients involved in the mammography 
screening process influence Black women’s responses to receiving a FPM result. While 
no factors were associated with patients’ general satisfaction and satisfaction with 
provider’s interpersonal style, organizational level factors related to the patient 
population, services offered, and the physical environment had an impact on patients’ 
satisfaction with provider’s skills and physical environment of the mammography 
facility. Provider perceptions of patients’ comfort were associated with patients’ 
satisfaction with providers’ skills. Patient characteristics related to past and current 
screening experiences including a family history of BrCa, experiencing discrimination 
during the most recent screening experience, and receiving a FPM result negatively 
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impacted mammography satisfaction. These same characteristics had similar negative 
effects on BrCa screening beliefs and attitudes.  
FPM status was associated with increased levels of general and breast cancer 
anxiety, but subsequently these emotional states did not influence BrCa screening beliefs. 
Receipt of FPM results did have adverse effects on women’s intention to complete 
mammography screening and follow-up procedures through an increased perception of 
the barriers to mammography completion. Culturally-specific behavior in the form of 
collective coping strategies weakened the effect of perceived barriers on screening 
intention. Together, these findings point to the potential role of past screening 
experiences on future screening behavior through influences on BrCa screening beliefs 
and intention. Additionally, these results also underscore the value and necessity of 
understanding the contextual influences of the group whose health outcomes are being 
investigated. Knowledge of the historical, social, and cultural factors that surround the 
health behaviors of groups, such as Black women, can inform the measurement of 
culturally-appropriate experiences and behaviors and the development of culturally-
relevant health behavior theories. This research has important implications for clinical 
practice and public health research as a whole, and with specific ramifications for those 
engaging in activities designed to reduce racial inequities in BrCa burden.  
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5.4 Implications and Recommendations 
5.4.1 Clinical Care 
Insights generated from this research suggest several strategies that can be 
employed to improve the screening and follow-up process for Black women. One 
important result of this research is the lack of facility-level differences in mammography 
satisfaction, which may be attributed to the standardization of notification procedures 
across facilities. Despite differences in patient populations, services, and clinical 
environments, women requiring additional testing are contacted via telephone after their 
initial mammogram is read (often within 24 hours) and by postal mail (regardless of 
phone contact) at all facilities. Analyses did reveal that providers’ communication about 
screening and perceptions of patients had an impact on Black women’s satisfaction with 
the encounter. It would stand to reason that the standardization of notification procedures 
may be one strategy that can improve Black women’s satisfaction with the 
mammography encounter. 
The development and testing of standardized scripts to guide provider 
interactions, particularly around follow-up testing may improve satisfaction with the 
clinical encounter. As part of these scripts, providers can also encourage Black women 
with FPM results to speak to their family and friends about their screening results to 
reduce their perception of the challenges of completing follow up-testing. Additionally, 
study results indicated that the presence of materials with information about the screening 
process had a positive impact on Black women’s screening and follow-up experiences. 
Making standard patient education materials from Susan G. Komen or the American 
Cancer Society available in the waiting room and/or including these materials with postal 
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notifications of abnormal results can address some of the communication issues 
commonly reported by this population. 
Lastly, Black women with FPM results reported less satisfaction with the 
convenience of mammography and were more aware of the barriers to completing 
screening. Survey items measuring satisfaction with convenience described logistical 
challenges related to the time needed for, distance to, and validity of follow up visits. The 
aforementioned factors can impact whether a woman is able to return for follow-up or the 
length of time it takes to achieve diagnostic resolution. Changes in the scheduling of 
screening can reduce some of the negative effects of FPM. Instead of scheduling all 
women for screening mammograms in time slots reserved for general screening, women 
who are likely to have FPM results could be given the option of complete screening 
during diagnostic screening slots.  
In the participating hospital system, mammography facilities held blocks of time 
specifically for women who need to return for follow up procedures. Women are 
informed that their visit will take longer, because the radiologist performing the 
procedure will read the images while the woman is waiting. If necessary, the radiologist 
will perform additional procedures so that the woman can receive a final result in person, 
unless a biopsy is required. If a woman completes a biopsy as part of her follow up 
procedures, a pathologist needs to process the tissue sample and prepare a final report. A 
nurse is scheduled to call the woman and inform her of the pathology results within 24 
hours of the biopsy. Women who are likely to have a FPM result could be offered the 
option of proceeding with their screening as it if was a follow-up visit and schedule their 
visit during one of the diagnostic testing slots. Providing women with this option has the 
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potential to address the logistical barriers in addition to communication issues related to 
follow-up testing. Providing educational materials about mammography follow-up to 
women suspected of FPM results while waiting for screening and diagnostic testing can 
reduce fears and other negative psychological outcomes. 
Although it is not possible to predict which women will have abnormal screening 
mammograms, there are several characteristics that increase the likelihood of receiving a 
FPM result. Women with dense breasts (BI-RADS Breast Density rating of 3 or 4), who 
are completing their first mammogram, and those with previous FPM results can be 
identified and offered the choice of completing initial screening during periods reserved 
for diagnostic follow-up periods. Women with increased risks of FPM who complete 
mammography during these slots would be asked to stay longer so that their initial 
mammograms can be read on site. These women would complete diagnostic testing on 
site if necessary. 
5.3.1 Population Level Mammography Screening Behavior 
In fall 2015, a few months before the start of data collection for this study, the 
American Cancer Society changed its mammography screening guidelines and 
recommended that average risk women began screening at age 45 and continue screening 
annually until age 54.51 After age 55, women can choose to screen annually or 
biennially.51 These guidelines differ from the American Cancer Society’s previous 
guidelines recommending annual mammography for women starting at age 40, and the 
United States Preventive Services Task Force’s more controversial guidelines 
recommending biennial mammograms for women between the ages of 50 and 74.286,287 
Negative consequences of FPM results, including additional financial costs and negative 
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psychosocial outcomes, were an integral factor in recent decisions to increase the age of 
screening initiation and lengthen screening intervals.51,287,288 In the case of Black women, 
these changes have been criticized as the evidence that informed these changes utilized 
samples (actual and simulated) of White women, thus the evidence did not account for 
racial differences in the age at BrCa diagnosis, BrCa tumor severity, incidence, or 
mortality.289 Additionally, the research forming the basis of these recommendations does 
not consider the lack of research on FPM outcomes in Black women. As a result, the 
current study is one of the few that can take up the discussion of the impact of FPM in 
Black women and the potential implications on population-level screening behaviors for 
this group. Several studies indicate that Black women continue to commence annual 
mammography screening at age 40, meaning that FPM rates are unlikely to change for 
this group.253,280,290–292 Some researchers speculate that the persistence of screening 
behavior may be a result of women and/or their provider’s lack of knowledge around or 
skepticism towards the new screening guidelines.263,280,292 Published data and findings 
from the current study revealed low rates of provider recommendation for mammography 
among Black women. These findings appear to support the idea that Black women are 
skeptical of or unaware of the guideline changes and provide more evidence as to the 
different healthcare contexts that surround Black women’s healthcare experiences.263 
Overall, trends in Black women’s mammography screening behaviors underscore the 
need to develop strategies to mitigate the potentially negative influences of FPM results 
on Black women’s BrCa screening beliefs and behaviors.  
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5.3.2 Theory Development and Application in Health Equity Research 
Considering the results of this study, future research on the influences on 
mammography follow-up in Black women should seek to integrate health behavior 
theories and theories guiding the organization and processes associated with clinical 
services. Much of the FPM literature focuses on the influence of clinical processes on 
outcomes without adequate consideration of the factors that drive the adoption of 
screening behaviors. Specifically, more work needs to be done to find and develop 
theories that accurately predict mammography behavior in different racial and ethnic 
groups. Popular health behaviors theories such as the health belief model or the theory of 
reasoned action and planned behavior have not been consistently related to 
mammography behaviors across various racial and ethnic groups.189,274,285 Even 
considering the theoretical constructs that consistently influence mammography 
screening outcomes, various operationalizations of these constructs exist, but the vast 
majority of scales have not been developed with women of color. This study used a 
culturally-relevant version of health belief model constructs and detected statistically 
significant relationships between one BrCa belief and mammography intention. Research 
needs to be conducted to develop reliable and valid measures that conceptualize 
behavioral constructs in different racial/ethnic groups. 
The transactional model of stress and coping has important applications to cancer 
prevention and health inequities research and should be explored in future studies. Much 
of the research on FPM focuses on psychosocial outcomes such as emotions in response 
to a stressful event, but the transactional model of stress and coping describes emotional 
responses occurring in a separate pathway from behaviors and/or changes in beliefs.200 
 
123 
Using the model to classify health-related events and potential responses to these events 
may improve researchers’ ability to understand and incorporate the impact of past 
experiences on an individual’s current cancer prevention beliefs and behaviors. In 
combination, the use of the previously mentioned theories and models would have the 
potential to enhance research and interventions devoted to improving the uptake of cancer 
screening behaviors across racial and ethnic groups.  
Lastly, theories and models used in health inequities research would benefit from 
explicitly focusing on the role of deep cultural factors such as social roles, norms, and 
behavior and the intersection of cultural factors with characteristics like gender, sexual 
orientation, and geography (rurality, region). A focus on deep cultural factors requires 
time spent considering how culture influences behavior along various intersections and 
how to assess these influences. Increased development and use of culturally-relevant 
measures of behaviors, beliefs, and attitudes is needed to discern culturally-specific 
nuances that shape health behaviors in different racial and ethnic groups.  
5.3.3 Assessment and Application of Multilevel Influences in Health Equity 
Research  
The socioecological model describes how characteristics at multiple levels 
(intrapersonal, interpersonal, community, organizational, and policy) influence health 
behavior, with abnormal mammography results serving as the perfect demonstration of 
how these levels converge for one health behavior (achieving diagnostic resolution).221,244 
Given the role of federal and state level health policy, institutional policies and practices, 
and physical and social aspects of the environment in creating and maintaining racially 
driven health inequities, multilevel interventions are needed to enhance health 
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equity.293,294 As part of this study, multilevel influences on mammography satisfaction 
were investigated and many of the challenges associated with multilevel analysis were 
highlighted in the process. While influences on satisfaction were detected at each of the 
three levels measured, stable multilevel models could not be created due to the small 
sample size of patient participants. Sample size was also challenge at the site level as 
there were only five mammography facilities. The small sample size and limited 
procedures available to compensate for the lack of variety in the sample prevented a 
comprehensive analysis of the relative contributions of each level to the behavior studied 
and/or interactions between levels.293 Despite the primarily descriptive nature of the 
analyses conducted, multilevel influences were operationalized and measured in this 
study. These processes and findings can be used to guide future efforts to examine 
screening behaviors in different groups using more advanced methods and larger 
samples. 
5.4 Future Research Directions 
Additional data were collected as part of this study, but were not included in the 
specific aims of this study given the small sample size and the desire to not to overfit 
regression models. Future research on this topic will take the form of:  1) Secondary 
analyses of dissertation data and 2) New studies building on the findings of this 
investigation. Additional analyses include investigations of the relationship between 
mammography satisfaction and intention. Mammography satisfaction is an understudied 
topic, but very few studies attempt to link women’s satisfaction in the mammography 
encounter with their intention to complete future mammography behavior. Of the existing 
research, few have been conducted with Black women. Items from the patient survey will 
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be used to develop models examining the relationship between various domains of 
mammography satisfaction and mammography intention in Black women. The 
explanatory power of culturally relevant influences such as experiencing discrimination 
during the clinical encounter will also be explored in this analysis.  
As a result of the changes in mammography screening guidelines and new 
research reporting that Black women receive fewer provider recommendations for 
mammography, items assessing awareness of changes in mammography screening 
guidelines, and participation in conversations with primary care providers regarding 
mammography screening intervals were included in the patient survey. Self-reported 
screening histories were verified with medical records and that information in 
combination, with the knowledge, awareness, and conversation variables will be used to 
determine what (if any) mammography screening guidelines were followed by patient 
participants.  
Breast density is another important factor that may influence Black women’s BrCa 
screening behavior, but very few studies examine Black women’s knowledge of their 
own breast density, and/or their understanding as to how breast density impacts their 
BrCa risk. Even less research is devoted to understanding how mammography providers 
describe breast density. Open-ended items from the patient and provider surveys will be 
used to explore patients’ perceptions of and reactions to having dense breasts and the 
ways that providers communicate with women about this issue. 
As previously mentioned, mammography screening behavior can be influenced by 
factors at multiple levels. Community or neighborhood is another factor that has been 
shown to impact mammography screening behaviors. Screening data used to classify 
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facilities will be merged with spatial variables to measure the impact of neighborhood 
and individual characteristics on mammography follow-up times. 
New studies will focus on the role of coping behaviors on mammography 
screening beliefs and behaviors in a racially diverse group of women with FPM results. 
Data from this and other studies suggest that coping and BrCa screening beliefs are 
grounded in cultural factors, and their impact on BrCa screening intention may vary by 
racial/ethnic group. A study is planned to collect qualitative data to explore experiences 
with and responses to the receipt of FPM results among Black women, White women, 
and Latinas in rural North Carolina. The analysis of the influence of coping behaviors on 
BrCa screening beliefs is novel and has the potential to impact the development of 
intervention strategies to change BrCa screening beliefs and mammography behaviors in 
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